BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
573917	CCc3cc(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](COC)C(=O)O)on3	InChI=1S/C27H30ClFN2O5/c1-4-21-15-25(36-31-21)26(32)30-22(13-19(16-34-3)27(33)35-5-2)12-17-6-8-18(9-7-17)23-14-20(28)10-11-24(23)29/h6-11,14-15,19,22H,4-5,12-13,16H2,1-3H3,(H,30,32)	HGQKHNBSYOXEIE-UHFFFAOYSA-N	299347	US9593110, Example 1::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3-ethylisoxazole-5-carbonyl)amino]-2-methoxymethylpentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299347&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			91826238	381614306							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573918	NC(=O)C[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C22H23N5O4/c23-20(28)12-17(22(30)31)11-18(25-21(29)19-13-24-27-26-19)10-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-9,13,17-18H,10-12H2,(H2,23,28)(H,25,29)(H,30,31)(H,24,26,27)	XLJGTFLHBYFUAW-UHFFFAOYSA-N	299348	US9593110, Example 53::(2S,4S)-5-Biphenyl-4-yl-2-carbamoylmethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299348	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299348&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252322	381614307							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573919	NC(=O)C[C@@H](C[C@@H](Cc2ccc(c1cccc(F)c1)cc2)NC(=O)C3CN=NN3)C(=O)O	InChI=1S/C21H27BFNO4/c1-3-28-21(26)18(14-25)13-20(24-22(2)27)11-15-7-9-16(10-8-15)17-5-4-6-19(23)12-17/h4-10,12,18,20,24-25,27H,3,11,13-14H2,1-2H3	BEQRCZIOYWCDLK-UHFFFAOYSA-N	299352	US9593110, Example 54::(2R,4S)-2-Carbamoylmethyl-5-(3&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299352	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299352&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255159	381614311							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573920	CC(C)C3=COC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2Cl)C[C@@H](N)C(=O)O)N3	InChI=1S/C24H22Cl2FN5O4/c1-12(2)21-11-36-23(30-21)22(33)29-16(10-20(24(34)35)31-32-28)7-14-4-3-13(8-18(14)26)17-9-15(25)5-6-19(17)27/h3-6,8-9,11-12,16,20H,7,10H2,1-2H3,(H,29,33)(H,34,35)	RRTKKKSXLWZPIY-UHFFFAOYSA-N	299353	US9593110, Example 17::(2R,4R)-2-Amino-5-(3,5&#8242;-dichloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(4-isopropyloxazole-2-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299353	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299353&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255160	381614312							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573921	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)Cn4ccnn4	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299355	US9593110, Example 61a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299355&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255161	381614314							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573922	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)Cn4nccn4	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299356	US9593110, Example 61b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299356	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299356&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255162	527830702							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573923	OC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)Cc1nnn[nH]1 |r|	InChI=1S/C22H20ClFN8O3/c23-15-5-6-18(24)17(10-15)13-3-1-12(2-4-13)7-16(26-21(33)19-11-25-30-27-19)8-14(22(34)35)9-20-28-31-32-29-20/h1-6,10-11,14,16H,7-9H2,(H,26,33)(H,34,35)(H,25,27,30)(H,28,29,31,32)	MRRNMXHHHZNSHA-UHFFFAOYSA-N	299357	US9593110, Example 63::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(1H-tetrazol-5-ylmethyl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299357	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299357&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252281	381614315							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573924	CN(C)CC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C24H26ClFN6O4/c1-32(2)13-22(33)29-20(24(35)36)11-17(28-23(34)21-12-27-31-30-21)9-14-3-5-15(6-4-14)18-10-16(25)7-8-19(18)26/h3-8,10,12,17,20H,9,11,13H2,1-2H3,(H,28,34)(H,29,33)(H,35,36)(H,27,30,31)	RADNPJONMBJKIW-UHFFFAOYSA-N	299359	US9593110, Example 64::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(2-dimethylaminoacetylamino)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299359	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299359&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252442	381614317							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573925	CNCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C23H24ClFN6O4/c1-26-12-21(32)29-19(23(34)35)10-16(28-22(33)20-11-27-31-30-20)8-13-2-4-14(5-3-13)17-9-15(24)6-7-18(17)25/h2-7,9,11,16,19,26H,8,10,12H2,1H3,(H,28,33)(H,29,32)(H,34,35)(H,27,30,31)	OVEIPQKMZFWMRO-UHFFFAOYSA-N	299361	US9593110, Example 65::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(2-methylaminoacetylamino)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299361	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299361&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252449	381614319							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573926	CCOC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C\C(N)=N/O |r|	InChI=1S/C24H26ClFN6O4/c1-2-36-24(34)16(11-22(27)31-35)10-18(29-23(33)21-13-28-32-30-21)9-14-3-5-15(6-4-14)19-12-17(25)7-8-20(19)26/h3-8,12-13,16,18,35H,2,9-11H2,1H3,(H2,27,31)(H,29,33)(H,28,30,32)	ABFBEAYRYQCBBJ-UHFFFAOYSA-N	299362	US9593110, Example 66::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(5-oxo-4,5-dihydro-[1,2,4]oxadiazol-3-ylmethyl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299362	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299362&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118259151	381614320							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573927	COC(=O)NCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C24H24ClFN6O6/c1-38-24(37)27-12-21(33)30-19(23(35)36)10-16(29-22(34)20-11-28-32-31-20)8-13-2-4-14(5-3-13)17-9-15(25)6-7-18(17)26/h2-7,9,11,16,19H,8,10,12H2,1H3,(H,27,37)(H,29,34)(H,30,33)(H,35,36)(H,28,31,32)	IUYNSERVQZNCSE-UHFFFAOYSA-N	299369	US9593110, Example 67::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(2-methoxycarbonylaminoacetylamino)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299369	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299369&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252353	381614327							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573928	NC[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C23H25ClFN5O3/c1-2-33-23(32)16(12-26)10-18(28-22(31)21-13-27-30-29-21)9-14-3-5-15(6-4-14)19-11-17(24)7-8-20(19)25/h3-8,11,13,16,18H,2,9-10,12,26H2,1H3,(H,28,31)(H,27,29,30)	XQXQHIMJAGHEIE-UHFFFAOYSA-N	299386	US9593110, Example 20::(2S,4S)-2-Aminomethyl-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299386	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299386&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252247	381614344							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573929	NCCCC(=O)NC[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3cnn[nH]3)C(=O)O	InChI=1S/C26H29BClFN6O5/c28-19-7-8-22(29)21(12-19)17-5-3-16(4-6-17)10-20(33-25(38)23-14-32-35-34-23)11-18(26(39)40)13-30-24(37)2-1-9-31-27-15-36/h3-8,12,14-15,18,20,27,31H,1-2,9-11,13H2,(H,30,37)(H,33,38)(H,39,40)(H,32,34,35)	DWMWIHGMKDIWLE-UHFFFAOYSA-N	299393	US9593110, Example 68::(2S,4S)-2-[(4-Aminobutyrylamino)methyl]-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic acid	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299393	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299393&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252483	381614351							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573930	COC[C@H](C[C@@H](Cc2ccc(c1cccc(Cl)c1)cc2)NC(=O)c3cnn[nH]3)C(=O)O	InChI=1S/C24H27ClN4O4/c1-3-33-24(31)19(15-32-2)13-21(27-23(30)22-14-26-29-28-22)11-16-7-9-17(10-8-16)18-5-4-6-20(25)12-18/h4-10,12,14,19,21H,3,11,13,15H2,1-2H3,(H,27,30)(H,26,28,29)	HORQBCMJJWOUAO-UHFFFAOYSA-N	299394	US9593110, Example 3::(2S,4S)-5-(3&#8242;-Chlorobiphenyl-4-yl)-2-methoxymethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299394	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299394&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252427	381614352							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573931	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)CN4CCOCC4	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299399	US9593110, Example 69a::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-morpholin-4-ylmethyl-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299399	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299399&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255163	527830703							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573932	NCCCCCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C26H30ClFN6O4/c27-18-9-10-21(28)20(13-18)17-7-5-16(6-8-17)12-19(31-25(36)23-15-30-34-33-23)14-22(26(37)38)32-24(35)4-2-1-3-11-29/h5-10,13,15,19,22H,1-4,11-12,14,29H2,(H,31,36)(H,32,35)(H,37,38)(H,30,33,34)	BZZCXWQEVFWJHY-UHFFFAOYSA-N	299445	US9593110, Example 70::(2R,4R)-2-(6-Aminohexanoylamino)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299445	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299445&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528943	381614400							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573933	CNCCCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C25H28ClFN6O4/c1-28-10-2-3-23(34)31-21(25(36)37)13-18(30-24(35)22-14-29-33-32-22)11-15-4-6-16(7-5-15)19-12-17(26)8-9-20(19)27/h4-9,12,14,18,21,28H,2-3,10-11,13H2,1H3,(H,30,35)(H,31,34)(H,36,37)(H,29,32,33)	SIXIVIJYYRRVOT-UHFFFAOYSA-N	299466	US9593110, Example 71::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(4-methylamino-butyrylamino)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299466	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299466&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528944	381614421							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573934	COC[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C24H28N4O4/c1-3-32-24(30)20(16-31-2)14-21(26-23(29)22-15-25-28-27-22)13-17-9-11-19(12-10-17)18-7-5-4-6-8-18/h4-12,15,20-21H,3,13-14,16H2,1-2H3,(H,26,29)(H,25,27,28)	CATGXVFSQWSLKK-UHFFFAOYSA-N	299493	US9593110, Example 5::(2S,4S)-5-Biphenyl-4-yl-2-methoxymethyl-4-[(1H-[1,2,3]-triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299493	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299493&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252287	381614447							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573935	NCCCCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C25H28ClFN6O4/c26-17-8-9-20(27)19(12-17)16-6-4-15(5-7-16)11-18(30-24(35)22-14-29-33-32-22)13-21(25(36)37)31-23(34)3-1-2-10-28/h4-9,12,14,18,21H,1-3,10-11,13,28H2,(H,30,35)(H,31,34)(H,36,37)(H,29,32,33)	JIMFKTJVZONUPZ-UHFFFAOYSA-N	299495	US9593110, Example 72::(2R,4R)-2-(5-Amino-pentanoylamino)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299495	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299495&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528945	381614449							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573936	CCOC[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3n[nH]c(C(F)(F)F)n3)C(=O)O	InChI=1S/C26H27ClF4N4O4/c1-3-38-14-17(24(37)39-4-2)12-19(32-23(36)22-33-25(35-34-22)26(29,30)31)11-15-5-7-16(8-6-15)20-13-18(27)9-10-21(20)28/h5-10,13,17,19H,3-4,11-12,14H2,1-2H3,(H,32,36)(H,33,34,35)	ITMHQODUFPLYQP-UHFFFAOYSA-N	299496	US9593110, Example 6::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-ethoxymethyl-4-[(5-trifluoromethyl-1H-[1,2,4]triazole-3-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299496	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299496&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252392	381614450							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573937	CN(C)CCCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C26H30ClFN6O4/c1-34(2)11-3-4-24(35)31-22(26(37)38)14-19(30-25(36)23-15-29-33-32-23)12-16-5-7-17(8-6-16)20-13-18(27)9-10-21(20)28/h5-10,13,15,19,22H,3-4,11-12,14H2,1-2H3,(H,30,36)(H,31,35)(H,37,38)(H,29,32,33)	WJDSHOMBLUTOKG-UHFFFAOYSA-N	299498	US9593110, Example 73::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(4-dimethylaminobutyrylamino)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299498	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299498&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528946	381614452							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573938	COCCCNC[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C(=O)O	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299499	US9593110, Example 74::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-[(3-methoxypropylamino)-methyl]-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299499	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299499&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255164	527830704							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573939	CN(C)C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C(=O)O	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299620	US9593110, Example 75::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-dimethylaminomethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299620	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299620&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255165	527830705							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573940	O=C(O)[C@@H](CC(Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)c4ccccn4	InChI=1S/C24H25BClFN2O3/c1-25(31)29-19(15-21(24(30)32-2)23-5-3-4-12-28-23)13-16-6-8-17(9-7-16)20-14-18(26)10-11-22(20)27/h3-12,14,19,21,29,31H,13,15H2,1-2H3	AIRIDQPZZCZVSJ-UHFFFAOYSA-N	299621	US9593110, Example 76::(S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-pyridin-2-yl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 22								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299621	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299621&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255166	381614573							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573941	O=C(O)[C@@H](C[C@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C4C=NC=CC4	InChI=1S/C25H27BClFN2O3/c1-3-33-25(31)23(19-5-4-12-29-16-19)15-21(30-26(2)32)13-17-6-8-18(9-7-17)22-14-20(27)10-11-24(22)28/h4-12,14,16,21,23,30,32H,3,13,15H2,1-2H3	IISGDIFNXQQFGK-UHFFFAOYSA-N	299622	US9593110, Example 77a	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299622	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299622&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255167	381614574							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573942	NC[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C23H32BNO5S/c1-4-30-23(26)21(14-15-31(3,28)29)17-22(25-24(2)27)16-18-10-12-20(13-11-18)19-8-6-5-7-9-19/h5-13,21-22,25,27H,4,14-17H2,1-3H3	REGLIHPVVIXYRY-UHFFFAOYSA-N	299623	US9593110, Example 22::(2S,4S)-2-Aminomethyl-5-biphenyl-4-yl-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299623	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299623&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255168	381614575							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573943	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C4C=NC=CC4	InChI=1S/C25H27BClFN2O3/c1-3-33-25(31)23(19-5-4-12-29-16-19)15-21(30-26(2)32)13-17-6-8-18(9-7-17)22-14-20(27)10-11-24(22)28/h4-12,14,16,21,23,30,32H,3,13,15H2,1-2H3	IISGDIFNXQQFGK-UHFFFAOYSA-N	299624	US9593110, Example 77b	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299624	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299624&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255169	527830706							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573944	CC3=CNC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](CCN)C(=O)O)O3	InChI=1S/C23H30BClFNO5S/c1-4-32-23(28)18(11-12-33(3,30)31)14-20(27-24(2)29)13-16-5-7-17(8-6-16)21-15-19(25)9-10-22(21)26/h5-10,15,18,20,27,29H,4,11-14H2,1-3H3	ZQSQDHDPLSPLCV-UHFFFAOYSA-N	299625	US9593110, Example 23::(2R,4S)-2-(2-Aminoethyl)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299625	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299625&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255170	381614576							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573945	O=C(O)[C@H](CC(Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C4CC=CS4	InChI=1S/C24H26BClFNO3S/c1-3-31-24(29)21(23-5-4-12-32-23)15-19(28-25(2)30)13-16-6-8-17(9-7-16)20-14-18(26)10-11-22(20)27/h4-12,14,19,21,28,30H,3,13,15H2,1-2H3	IBUQFPIHRBMBQI-UHFFFAOYSA-N	299626	US9593110, Example 78::(S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-thiophen-2-yl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299626	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299626&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255171	381614577							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573946	O=C(O)[C@@H](CC(Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)c4ccsc4	InChI=1S/C24H26BClFNO3S/c1-3-31-24(29)22(18-10-11-32-15-18)14-20(28-25(2)30)12-16-4-6-17(7-5-16)21-13-19(26)8-9-23(21)27/h4-11,13,15,20,22,28,30H,3,12,14H2,1-2H3	GCQLBJJBWNTJHU-UHFFFAOYSA-N	299627	US9593110, Example 79::(S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-thiophen-3-yl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299627	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299627&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255172	381614578							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573947	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Br)c1)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C22H23BrN4O4/c1-31-13-17(22(29)30)11-19(25-21(28)20-12-24-27-26-20)9-14-5-7-15(8-6-14)16-3-2-4-18(23)10-16/h2-8,10,12,17,19H,9,11,13H2,1H3,(H,25,28)(H,29,30)(H,24,26,27)	OPKTZIWUNBOBHW-UHFFFAOYSA-N	299628	US9593110, Example 80::(2S,4S)-5-(3&#8242;-Bromobiphenyl-4-yl)-2-methoxymethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299628	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299628&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252289	381614579							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573948	CC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C22H22FN5O4/c1-13(29)25-19(22(31)32)11-16(26-21(30)20-12-24-28-27-20)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)23/h2-9,12,16,19H,10-11H2,1H3,(H,25,29)(H,26,30)(H,31,32)(H,24,27,28)	DNTSEWZWQNAPFI-UHFFFAOYSA-N	299629	US9593110, Example 25::(2R,4R)-2-Acetylamino-5-(2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299629	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299629&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252435	381614580					C02847		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573949	O=C(O)[C@H](CNCCF)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3	InChI=1S/C28H32BClFNO6S/c1-4-37-28(33)22(18-38-39(35,36)25-12-5-19(2)6-13-25)16-24(32-29(3)34)15-20-7-9-21(10-8-20)26-17-23(30)11-14-27(26)31/h5-14,17,22,24,32,34H,4,15-16,18H2,1-3H3	MQNUYORJAHRKHD-UHFFFAOYSA-N	299630	US9593110, Example 81::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-[(2-fluoroethylamino)methyl]-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299630	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299630&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255173	381614581							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573950	CC(=O)N[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C22H24N4O4/c1-2-30-22(29)20(27)13-18(24-21(28)19-14-23-26-25-19)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14,18,20,27H,2,12-13H2,1H3,(H,24,28)(H,23,25,26)	GCRQKHYCOSKGSR-UHFFFAOYSA-N	299631	US9593110, Example 26::(2R,4R)-2-Acetylamino-5-biphenyl-4-yl-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299631	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299631&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255174	381614582							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573951	O=C(O)[C@H](CNCC(F)F)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3	InChI=1S/C28H32BClFNO6S/c1-4-37-28(33)22(18-38-39(35,36)25-12-5-19(2)6-13-25)16-24(32-29(3)34)15-20-7-9-21(10-8-20)26-17-23(30)11-14-27(26)31/h5-14,17,22,24,32,34H,4,15-16,18H2,1-3H3	MQNUYORJAHRKHD-UHFFFAOYSA-N	299632	US9593110, Example 82a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299632	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299632&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255175	527830707							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573952	CCOC[C@H](C[C@@H](Cc2ccc(c1cccc(Cl)c1)cc2)NC(=O)c3cc(O)no3)C(=O)O	InChI=1S/C26H29ClN2O6/c1-3-33-16-20(26(32)34-4-2)14-22(28-25(31)23-15-24(30)29-35-23)12-17-8-10-18(11-9-17)19-6-5-7-21(27)13-19/h5-11,13,15,20,22H,3-4,12,14,16H2,1-2H3,(H,28,31)(H,29,30)	UQKXXHFWGRPQHA-UHFFFAOYSA-N	299633	US9593110, Example 8::(2S,4S)-5-(3&#8242;-Chlorobiphenyl-4-yl)-2-ethoxymethyl-4-[(3-hydroxyisoxazole-5-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299633	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299633&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252474	381614583							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573953	CC(=O)NC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C23H23ClFN5O4/c1-13(31)26-11-16(23(33)34)9-18(28-22(32)21-12-27-30-29-21)8-14-2-4-15(5-3-14)19-10-17(24)6-7-20(19)25/h2-7,10,12,16,18H,8-9,11H2,1H3,(H,26,31)(H,28,32)(H,33,34)(H,27,29,30)	ZYFCMARBLBKDIT-UHFFFAOYSA-N	299634	US9593110, Example 28::(2S,4S)-2-(Acetylaminomethyl)-5-(5&#8242;-chloro-2&#8242;-fluoro-biphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299634	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299634&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528956	381614584							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573954	CCc1cc(on1)C(=O)N[C@@H](C[C@@H](CNC(=O)OC)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F |r|	InChI=1S/C26H27ClFN3O6/c1-3-19-13-23(37-31-19)24(32)30-20(11-17(25(33)34)14-29-26(35)36-2)10-15-4-6-16(7-5-15)21-12-18(27)8-9-22(21)28/h4-9,12-13,17,20H,3,10-11,14H2,1-2H3,(H,29,35)(H,30,32)(H,33,34)	IGBXAYCVVLRWLQ-UHFFFAOYSA-N	299635	US9593110, Example 29::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3-ethylisoxazole-5-carbonyl)amino]-2-methoxycarbonylaminopentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299635	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299635&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118260653	381614585							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573955	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)CN4CC(O)C4	InChI=1S/C28H32BClFNO6S/c1-4-37-28(33)22(18-38-39(35,36)25-12-5-19(2)6-13-25)16-24(32-29(3)34)15-20-7-9-21(10-8-20)26-17-23(30)11-14-27(26)31/h5-14,17,22,24,32,34H,4,15-16,18H2,1-3H3	MQNUYORJAHRKHD-UHFFFAOYSA-N	299636	US9593110, Example 83b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299636	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299636&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255176	527830708							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573956	O=C(O)[C@@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CN=NN3)CN4CCC4	InChI=1S/C28H32BClFNO6S/c1-4-37-28(33)22(18-38-39(35,36)25-12-5-19(2)6-13-25)16-24(32-29(3)34)15-20-7-9-21(10-8-20)26-17-23(30)11-14-27(26)31/h5-14,17,22,24,32,34H,4,15-16,18H2,1-3H3	MQNUYORJAHRKHD-UHFFFAOYSA-N	299637	US9593110, Example 84b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299637	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299637&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255177	527830709							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573957	COCCN(C)C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C(=O)O	InChI=1S/C28H32BClFNO6S/c1-4-37-28(33)22(18-38-39(35,36)25-12-5-19(2)6-13-25)16-24(32-29(3)34)15-20-7-9-21(10-8-20)26-17-23(30)11-14-27(26)31/h5-14,17,22,24,32,34H,4,15-16,18H2,1-3H3	MQNUYORJAHRKHD-UHFFFAOYSA-N	299638	US9593110, Example 85a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299638	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299638&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255178	527830710							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573958	CCOC[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C25H30N4O4/c1-3-32-17-21(25(31)33-4-2)15-22(27-24(30)23-16-26-29-28-23)14-18-10-12-20(13-11-18)19-8-6-5-7-9-19/h5-13,16,21-22H,3-4,14-15,17H2,1-2H3,(H,27,30)(H,26,28,29)	KLZRABFSACFVLS-UHFFFAOYSA-N	299639	US9593110, Example 10::(2S,4S)-5-Biphenyl-4-yl-2-ethoxymethyl-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299639	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299639&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252429	381614586							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573959	O=C(O)[C@H](COCCO)C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)c3c[nH]nn3	InChI=1S/C25H30N4O5/c1-2-34-25(32)21(17-33-13-12-30)15-22(27-24(31)23-16-26-29-28-23)14-18-8-10-20(11-9-18)19-6-4-3-5-7-19/h3-11,16,21-22,30H,2,12-15,17H2,1H3,(H,27,31)(H,26,28,29)	UWHVNGJDLZPMHO-UHFFFAOYSA-N	299640	US9593110, Example 11::(2S,4S)-5-Biphenyl-4-yl-2-(2-hydroxyethoxymethyl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299640	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299640&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252428	381614587							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573960	O=C(O)[C@H](COCCCO)C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)c3c[nH]nn3	InChI=1S/C26H32N4O5/c1-2-35-26(33)22(18-34-14-6-13-31)16-23(28-25(32)24-17-27-30-29-24)15-19-9-11-21(12-10-19)20-7-4-3-5-8-20/h3-5,7-12,17,22-23,31H,2,6,13-16,18H2,1H3,(H,28,32)(H,27,29,30)	GICRJZFTSGPZLA-UHFFFAOYSA-N	299641	US9593110, Example 12::(2S,4S)-5-Biphenyl-4-yl-2-(3-hydroxypropoxymethyl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299641	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299641&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252265	381614588							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573961	O=C(O)[C@H](CNCCCO)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299642	US9593110, Example 87b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299642	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299642&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255179	381614589							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573962	N[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C20H17ClFN7O3/c21-13-5-6-16(22)15(8-13)12-3-1-11(2-4-12)7-14(9-17(20(31)32)26-28-23)25-19(30)18-10-24-29-27-18/h1-6,8,10,14,17H,7,9H2,(H,25,30)(H,31,32)(H,24,27,29)	BBFUUWCGBAHVIO-UHFFFAOYSA-N	299643	US9593110, Example 13::(2R,4R)-2-Amino-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299643	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299643&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255180	381614590							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573963	CCOC(=O)[C@H](N)C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1 |r|	InChI=1S/C22H23ClFN5O3/c1-2-32-22(31)19(25)11-16(27-21(30)20-12-26-29-28-20)9-13-3-5-14(6-4-13)17-10-15(23)7-8-18(17)24/h3-8,10,12,16,19H,2,9,11,25H2,1H3,(H,27,30)(H,26,28,29)	JJLAZPVWXVNFFM-UHFFFAOYSA-N	299644	US9593110, Example 14a::(2R,4R)-2-Amino-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid Ethyl Ester	Neprilysin	Human	 21								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299644	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299644&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252302	381614591					C03317		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573964	N#CC4CN(C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299645	US9593110, Example 88b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299645	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299645&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255181	527830711							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573965	CCCCCCOC(=O)[C@H](N)C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1 |r|	InChI=1S/C26H31ClFN5O3/c1-2-3-4-5-12-36-26(35)23(29)15-20(31-25(34)24-16-30-33-32-24)13-17-6-8-18(9-7-17)21-14-19(27)10-11-22(21)28/h6-11,14,16,20,23H,2-5,12-13,15,29H2,1H3,(H,31,34)(H,30,32,33)	VPKCBORBTIHYNC-UHFFFAOYSA-N	299646	US9593110, Example 14b::(2R,4R)-2-Amino-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid Hexyl Ester	Neprilysin	Human	 66								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299646	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299646&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252356	381614592					C03317		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573966	CC(C)c3coc(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](N)C(=O)O)n3	InChI=1S/C24H23ClFN5O4/c1-13(2)21-12-35-23(29-21)22(32)28-17(11-20(24(33)34)30-31-27)9-14-3-5-15(6-4-14)18-10-16(25)7-8-19(18)26/h3-8,10,12-13,17,20H,9,11H2,1-2H3,(H,28,32)(H,33,34)	NGBQVCXURSJWNG-UHFFFAOYSA-N	299647	US9593110, Example 15::(2R,4R)-2-Amino-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(4-isopropyloxazole-2-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299647	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299647&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252346	381614593							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573967	CC4(C)CN(C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299648	US9593110, Example 89b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299648	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299648&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255182	527830712							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573968	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)CN4CC(F)(F)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299649	US9593110, Example 90b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299649	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299649&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255183	527830713							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573969	NCC(=O)N[C@H](C[C@@H](Cc2ccc(c1ccccc1F)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C23H26BFN6O5/c1-24(36)26-13-21(32)29-19(23(34)35)11-16(28-22(33)20-12-27-31-30-20)10-14-6-8-15(9-7-14)17-4-2-3-5-18(17)25/h2-9,12,16,19,26,36H,10-11,13H2,1H3,(H,28,33)(H,29,32)(H,34,35)(H,27,30,31)	PTAHNUUMUASVQB-UHFFFAOYSA-N	299650	US9593110, Example 32::(2R,4R)-2-(2-Amino acetylamino)-5-(2&#8242;-fluorobiphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299650	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299650&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252214	381614594							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573970	NCC(=O)N[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C23H25BClFN6O5/c1-24(37)27-12-21(33)30-19(23(35)36)10-16(29-22(34)20-11-28-32-31-20)8-13-2-4-14(5-3-13)17-9-15(25)6-7-18(17)26/h2-7,9,11,16,19,27,37H,8,10,12H2,1H3,(H,29,34)(H,30,33)(H,35,36)(H,28,31,32)	IRGMTGNQORAWBZ-UHFFFAOYSA-N	299651	US9593110, Example 33::(2R,4R)-2-(2-Aminoacetylamino)-5-(5&#8242;-chloro-2&#8242;-fluoro-biphenyl-4-yl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299651	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299651&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252213	381614595							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573971	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)CN4CC(F)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299652	US9593110, Example 91b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299652	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299652&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255184	527830714							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573972	CC(C)c1coc(n1)C(=O)N[C@@H](C[C@@H](NC(=O)C(C)(C)N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F |r|	InChI=1S/C28H32ClFN4O5/c1-15(2)23-14-39-25(33-23)24(35)32-19(13-22(26(36)37)34-27(38)28(3,4)31)11-16-5-7-17(8-6-16)20-12-18(29)9-10-21(20)30/h5-10,12,14-15,19,22H,11,13,31H2,1-4H3,(H,32,35)(H,34,38)(H,36,37)	AYUXNFDYCHSKDZ-UHFFFAOYSA-N	299653	US9593110, Example 35::(2R,4R)-2-(2-Amino-2-methylpropionylamino)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(4-isopropyloxazole-2-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299653	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299653&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252334	381614596							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573973	O=C(O)[C@@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CN=NN3)CN4CC(CO)(CO)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299654	US9593110, Example 92b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299654	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299654&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255185	527830715							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573974	CC(C)C3=COC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](NC(=O)[C@H](C)N)C(=O)O)N3	InChI=1S/C27H30ClFN4O5/c1-14(2)23-13-38-26(33-23)25(35)31-19(12-22(27(36)37)32-24(34)15(3)30)10-16-4-6-17(7-5-16)20-11-18(28)8-9-21(20)29/h4-9,11,13-15,19,22H,10,12,30H2,1-3H3,(H,31,35)(H,32,34)(H,36,37)	HSTASQGIYPOGGP-UHFFFAOYSA-N	299655	US9593110, Example 36-1	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299655	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299655&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255186	381614597					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573975	CC(C)C3=COC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](NC(=O)[C@@H](C)N)C(=O)O)N3	InChI=1S/C27H30ClFN4O5/c1-14(2)23-13-38-26(33-23)25(35)31-19(12-22(27(36)37)32-24(34)15(3)30)10-16-4-6-17(7-5-16)20-11-18(28)8-9-21(20)29/h4-9,11,13-15,19,22H,10,12,30H2,1-3H3,(H,31,35)(H,32,34)(H,36,37)	HSTASQGIYPOGGP-UHFFFAOYSA-N	299656	US9593110, Example 36-2	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299656	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299656&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255187	527830716							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573976	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)CN4CC(CO)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299657	US9593110, Example 93b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299657	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299657&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255188	527830717							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573977	CC(C)[C@@H](N)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1nc(co1)C(C)C)C(O)=O |r|	InChI=1S/C29H34ClFN4O5/c1-15(2)24-14-40-28(35-24)27(37)33-20(13-23(29(38)39)34-26(36)25(32)16(3)4)11-17-5-7-18(8-6-17)21-12-19(30)9-10-22(21)31/h5-10,12,14-16,20,23,25H,11,13,32H2,1-4H3,(H,33,37)(H,34,36)(H,38,39)	MIFFESQEMNZDMV-UHFFFAOYSA-N	299658	US9593110, Example 38-1::US9593110, Example 38-2	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299658	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299658&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252293	381614598					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573978	O=C(O)[C@@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3cnn[nH]3)CN4C[C@H](CO)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299659	US9593110, Example 94b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299659	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299659&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252443	527830718							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573979	CC(C)c3coc(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](NC(=O)[C@@H](N)C(C)C)C(=O)O)n3	InChI=1S/C29H34ClFN4O5/c1-15(2)24-14-40-28(35-24)27(37)33-20(13-23(29(38)39)34-26(36)25(32)16(3)4)11-17-5-7-18(8-6-17)21-12-19(30)9-10-22(21)31/h5-10,12,14-16,20,23,25H,11,13,32H2,1-4H3,(H,33,37)(H,34,36)(H,38,39)	MIFFESQEMNZDMV-UHFFFAOYSA-N	299660	US9593110, Example 38-2	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299660	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299660&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252415	527830719							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573980	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CN=NN3)CN4CC[C@H]4CO	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299661	US9593110, Example 95b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299661	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299661&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255189	527830720							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573981	NCCCC(=O)N[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CN=NN3)C(=O)O	InChI=1S/C20H17ClFN7O3/c21-13-5-6-16(22)15(8-13)12-3-1-11(2-4-12)7-14(9-17(20(31)32)26-28-23)25-19(30)18-10-24-29-27-18/h1-6,8,10,14,17H,7,9H2,(H,25,30)(H,31,32)(H,24,27,29)	BBFUUWCGBAHVIO-UHFFFAOYSA-N	299662	US9593110, Example 40::(2R,4R)-2-(4-Aminobutyrylamino)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299662	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299662&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255190	381614599							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573982	NC(=O)C4CN(C[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3cnn[nH]3)C(=O)O)C4	InChI=1S/C27H30ClFN6O4/c1-2-39-27(38)18(13-35-14-19(15-35)25(30)36)10-21(32-26(37)24-12-31-34-33-24)9-16-3-5-17(6-4-16)22-11-20(28)7-8-23(22)29/h3-8,11-12,18-19,21H,2,9-10,13-15H2,1H3,(H2,30,36)(H,32,37)(H,31,33,34)	MFHJNIPUGNTFLQ-UHFFFAOYSA-N	299664	US9593110, Example 96b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299664	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299664&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252335	381614601							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573983	CC(C)C3=COC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](NC(=O)[C@H](N)CO)C(=O)O)N3	InChI=1S/C27H30ClFN4O6/c1-14(2)23-13-39-26(33-23)25(36)31-18(11-22(27(37)38)32-24(35)21(30)12-34)9-15-3-5-16(6-4-15)19-10-17(28)7-8-20(19)29/h3-8,10,13-14,18,21-22,34H,9,11-12,30H2,1-2H3,(H,31,36)(H,32,35)(H,37,38)	GLVZWAFDGSBFIA-UHFFFAOYSA-N	299665	US9593110, Example 42-1	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299665	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299665&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255191	381614602					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573984	COCCCN[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C21H26BClFNO6S/c1-4-30-21(26)20(31-32(3,28)29)13-17(25-22(2)27)11-14-5-7-15(8-6-14)18-12-16(23)9-10-19(18)24/h5-10,12,17,20,25,27H,4,11,13H2,1-3H3	RJEHVTLDQXHCFY-UHFFFAOYSA-N	299666	US9593110, Example 97a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299666	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299666&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255192	381614603							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573985	CC(C)C3=COC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](NC(=O)[C@@H](N)CO)C(=O)O)N3	InChI=1S/C27H30ClFN4O6/c1-14(2)23-13-39-26(33-23)25(36)31-18(11-22(27(37)38)32-24(35)21(30)12-34)9-15-3-5-16(6-4-15)19-10-17(28)7-8-20(19)29/h3-8,10,13-14,18,21-22,34H,9,11-12,30H2,1-2H3,(H,31,36)(H,32,35)(H,37,38)	GLVZWAFDGSBFIA-UHFFFAOYSA-N	299667	US9593110, Example 42-2	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299667	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299667&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255193	527830721							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573986	CC3=CNC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](CNC(=O)CN)C(=O)O)O3	InChI=1S/C21H26BClFNO4/c1-3-29-21(27)16(13-26)11-18(25-22(2)28)10-14-4-6-15(7-5-14)19-12-17(23)8-9-20(19)24/h4-9,12,16,18,25-26,28H,3,10-11,13H2,1-2H3	VDXSNKABWFMDLM-UHFFFAOYSA-N	299668	US9593110, Example 43::(2S,4S)-2-[(2-Aminoacetylamino)methyl]-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299668	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299668&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255194	381614604							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573987	CCOC(=O)[C@@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)C3CNN=N3)NCCCOC	InChI=1S/C21H26BClFNO6S/c1-4-30-21(26)20(31-32(3,28)29)13-17(25-22(2)27)11-14-5-7-15(8-6-14)18-12-16(23)9-10-19(18)24/h5-10,12,17,20,25,27H,4,11,13H2,1-3H3	RJEHVTLDQXHCFY-UHFFFAOYSA-N	299669	US9593110, Example 98a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299669	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299669&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255195	527830722							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573988	CC3=CNC(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@@H](CNC(=O)C(C)(C)N)C(=O)O)O3	InChI=1S/C28H33BClFN4O6/c1-16-14-32-25(41-16)24(36)34-21(12-19(26(37)38)15-33-27(39)28(2,3)35-29(4)40)11-17-5-7-18(8-6-17)22-13-20(30)9-10-23(22)31/h5-10,13-14,19,21,35,40H,11-12,15H2,1-4H3,(H,33,39)(H,34,36)(H,37,38)	TYSHHEQIVYCAQG-UHFFFAOYSA-N	299670	US9593110, Example 45	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299670	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299670&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255196	381614605							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573989	CN(C)CCOC[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C25H35BClFN2O4/c1-5-34-25(31)20(17-33-13-12-30(3)4)15-22(29-26(2)32)14-18-6-8-19(9-7-18)23-16-21(27)10-11-24(23)28/h6-11,16,20,22,29,32H,5,12-15,17H2,1-4H3	JFTAFOIHUXGXEG-UHFFFAOYSA-N	299671	US9593110, Example 100::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-(2-dimethylamino-ethoxymethyl)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299671	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299671&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255197	381614606							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573990	COC(=O)N[C@@H](C(C)C)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O |r|	InChI=1S/C27H30ClFN6O6/c1-14(2)23(33-27(40)41-3)25(37)32-21(26(38)39)12-18(31-24(36)22-13-30-35-34-22)10-15-4-6-16(7-5-15)19-11-17(28)8-9-20(19)29/h4-9,11,13-14,18,21,23H,10,12H2,1-3H3,(H,31,36)(H,32,37)(H,33,40)(H,38,39)(H,30,34,35)	CZFDWLLJORBNLF-UHFFFAOYSA-N	299672	US9593110, Example 46::(2R,4R)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-((S)-2-methoxycarbonylamino-3-methylbutyrylamino)-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299672	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299672&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528968	381614607							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573991	CC4(O)CN(C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299673	US9593110, Example 101b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299673	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299673&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255198	527830723							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573992	O=C(O)[C@H](CNCCO)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)n3ccnn3	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299674	US9593110, Example 48a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299674	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299674&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255199	527830724							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573993	CC4(O)CN(C[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299675	US9593110, Example 101c	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299675	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299675&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255200	527830725							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573994	O=C(O)[C@H](CNCCO)C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)c3cnn[nH]3	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299676	US9593110, Example 48b	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299676	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299676&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255201	527830726							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573995	COC4CN(C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299677	US9593110, Example 102b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299677	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299677&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255202	527830727							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573996	COCCNC[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)n3ccnn3)C(=O)O	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299678	US9593110, Example 49a	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299678	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299678&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255203	527830728							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573997	COC4CN(C[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299679	US9593110, Example 102c	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299679	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299679&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255204	527830729							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573998	COCCNC[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)c3cnn[nH]3)C(=O)O	InChI=1S/C22H28BClFNO6S/c1-4-31-22(27)17(14-32-33(3,29)30)12-19(26-23(2)28)11-15-5-7-16(8-6-15)20-13-18(24)9-10-21(20)25/h5-10,13,17,19,26,28H,4,11-12,14H2,1-3H3	REDOGQOARGHTGQ-UHFFFAOYSA-N	299680	US9593110, Example 49b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299680	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299680&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255205	527830730							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
573999	COC[C@H]1CCN1C[C@H](C[C@@H](Cc3ccc(C2=C(F)C=CC(Cl)C2)cc3)NC(=O)C4CN=NN4)C(=O)O	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299681	US9593110, Example 103b	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299681	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299681&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255206	527830731							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574000	N#CC[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)c3cnn[nH]3)C(=O)O	InChI=1S/C24H25N5O3/c1-2-32-24(31)20(12-13-25)15-21(27-23(30)22-16-26-29-28-22)14-17-8-10-19(11-9-17)18-6-4-3-5-7-18/h3-11,16,20-21H,2,12,14-15H2,1H3,(H,27,30)(H,26,28,29)	NWXZRFJRBFBSES-UHFFFAOYSA-N	299682	US9593110, Example 50::(2S,4S)-5-Biphenyl-4-yl-2-cyanomethyl-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299682	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299682&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252305	381614608							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574001	N#CC[C@H](C[C@@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)NC(=O)c3c[nH]nn3)C(=O)O	InChI=1S/C24H23ClFN5O3/c1-2-34-24(33)17(9-10-27)12-19(29-23(32)22-14-28-31-30-22)11-15-3-5-16(6-4-15)20-13-18(25)7-8-21(20)26/h3-8,13-14,17,19H,2,9,11-12H2,1H3,(H,29,32)(H,28,30,31)	NMXSKMCZEHJVDC-UHFFFAOYSA-N	299683	US9593110, Example 51::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-cyanomethyl-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299683	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299683&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252204	381614609							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574002	COC[C@@H]1CCN1C[C@H](C[C@@H](Cc3ccc(C2=C(F)C=CC(Cl)C2)cc3)NC(=O)C4CN=NN4)C(=O)O	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299684	US9593110, Example 103d	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299684	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299684&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255207	527830732							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574003	CC(C)(N)[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O |r|	InChI=1S/C23H25ClFN5O3/c1-23(2,26)18(22(32)33)11-16(28-21(31)20-12-27-30-29-20)9-13-3-5-14(6-4-13)17-10-15(24)7-8-19(17)25/h3-8,10,12,16,18H,9,11,26H2,1-2H3,(H,28,31)(H,32,33)(H,27,29,30)	LJVYDLBJOVNMNP-UHFFFAOYSA-N	299685	US9593110, Example 104::(2S,4S)-2-(1-Amino-1-methylethyl)-5-(5&#8242;-chloro-2&#8242;-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299685	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299685&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528969	381614610							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574004	O=C(O)[C@@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)CN4CC(CCO)C4	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299686	US9593110, Example 105::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-[3-(2-hydroxyethyl)azetidin-1-ylmethyl]-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299686	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299686&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255208	527830733							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574005	CN(CCO)C[C@H](C[C@@H](Cc2ccc(C1=C(F)C=CC(Cl)C1)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C27H29BBrClFNO6S/c1-3-37-27(33)20(17-38-39(35,36)24-11-8-21(29)9-12-24)15-23(32-28(2)34)14-18-4-6-19(7-5-18)25-16-22(30)10-13-26(25)31/h4-13,16,20,23,32,34H,3,14-15,17H2,1-2H3	XUESFXPWPSYPQC-UHFFFAOYSA-N	299687	US9593110, Example 106::(2S,4S)-5-(5&#8242;-Chloro-2&#8242;-fluorobiphenyl-4-yl)-2-{[(2-hydroxyethyl)-methylamino]methyl}-4-[(1H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid	Neprilysin	Homo sapiens	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=299687	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=299687&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255209	527830734							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574702	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1nn(-c2ccccc2)c(=O)[nH]1)C(O)=O	InChI=1S/C26H23ClFN5O4/c27-17-10-11-21(28)20(13-17)16-8-6-15(7-9-16)12-18(14-22(29)25(35)36)30-24(34)23-31-26(37)33(32-23)19-4-2-1-3-5-19/h1-11,13,18,22H,12,14,29H2,(H,30,34)(H,35,36)(H,31,32,37)	WVUOWOLSMWNWQR-UHFFFAOYSA-N	300247	US9593110, 16-35	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300247	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300247&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137190683	381615139							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574703	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C22H22ClFN4O4/c1-32-12-15(22(30)31)9-17(26-21(29)20-11-25-28-27-20)8-13-2-4-14(5-3-13)18-10-16(23)6-7-19(18)24/h2-7,10-11,15,17H,8-9,12H2,1H3,(H,26,29)(H,30,31)(H,25,27,28)	NGWPZEDKGHRSRU-UHFFFAOYSA-N	300248	US9593110, 2-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300248	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300248&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252234	381615140							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574704	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1n[nH]c(n1)C(F)(F)F)C(O)=O	InChI=1S/C23H21ClF4N4O4/c1-36-11-14(21(34)35)9-16(29-20(33)19-30-22(32-31-19)23(26,27)28)8-12-2-4-13(5-3-12)17-10-15(24)6-7-18(17)25/h2-7,10,14,16H,8-9,11H2,1H3,(H,29,33)(H,34,35)(H,30,31,32)	PMVAVHVYEOVEBT-UHFFFAOYSA-N	300249	US9593110, 2-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300249	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300249&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252490	381615141							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574705	OC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)NC(=O)[C@@H]1CCCN1	InChI=1S/C25H26ClFN6O4/c26-16-7-8-19(27)18(11-16)15-5-3-14(4-6-15)10-17(30-24(35)22-13-29-33-32-22)12-21(25(36)37)31-23(34)20-2-1-9-28-20/h3-8,11,13,17,20-21,28H,1-2,9-10,12H2,(H,30,35)(H,31,34)(H,36,37)(H,29,32,33)	VNWKXGSGGWYYBQ-UHFFFAOYSA-N	300250	US9593110, 55	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300250	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300250&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252202	381615142							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574706	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1[nH]nc(C2CC2)c1F)C(O)=O	InChI=1S/C26H26ClF2N3O4/c1-36-13-17(26(34)35)11-19(30-25(33)24-22(29)23(31-32-24)16-6-7-16)10-14-2-4-15(5-3-14)20-12-18(27)8-9-21(20)28/h2-5,8-9,12,16-17,19H,6-7,10-11,13H2,1H3,(H,30,33)(H,31,32)(H,34,35)	MODCSUNWQHSNGW-UHFFFAOYSA-N	300251	US9593110, 2-3	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300251	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300251&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252472	381615143							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574707	CC(C)c1coc(n1)C(=O)N[C@@H](C[C@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C24H24Cl2FN3O4/c1-12(2)21-11-34-23(30-21)22(31)29-16(10-20(28)24(32)33)7-14-4-3-13(8-18(14)26)17-9-15(25)5-6-19(17)27/h3-6,8-9,11-12,16,20H,7,10,28H2,1-2H3,(H,29,31)(H,32,33)	MVFURPFYPBMNFU-UHFFFAOYSA-N	300252	US9593110, 18-1	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300252	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300252&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252283	381615144							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574708	NCCCC[C@H](N)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C26H31ClFN7O4/c27-17-8-9-20(28)19(12-17)16-6-4-15(5-7-16)11-18(32-25(37)23-14-31-35-34-23)13-22(26(38)39)33-24(36)21(30)3-1-2-10-29/h4-9,12,14,18,21-22H,1-3,10-11,13,29-30H2,(H,32,37)(H,33,36)(H,38,39)(H,31,34,35)	HMJPVBSIPHLGAY-UHFFFAOYSA-N	300253	US9593110, 56	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300253	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300253&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252327	381615145					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574709	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(n[nH]1)C(C)=O)C(O)=O	InChI=1S/C25H25ClFN3O5/c1-14(31)22-12-23(30-29-22)24(32)28-19(10-17(13-35-2)25(33)34)9-15-3-5-16(6-4-15)20-11-18(26)7-8-21(20)27/h3-8,11-12,17,19H,9-10,13H2,1-2H3,(H,28,32)(H,29,30)(H,33,34)	MYMVFAMGKOKUOE-UHFFFAOYSA-N	300254	US9593110, 2-4	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300254	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300254&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528971	381615146							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574710	CCCc1nc(co1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C24H24Cl2FN3O4/c1-2-3-22-30-21(12-34-22)23(31)29-16(11-20(28)24(32)33)8-14-5-4-13(9-18(14)26)17-10-15(25)6-7-19(17)27/h4-7,9-10,12,16,20H,2-3,8,11,28H2,1H3,(H,29,31)(H,32,33)	BYVCBOWKLPVFOP-UHFFFAOYSA-N	300255	US9593110, 18-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300255	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300255&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252485	381615147							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574711	N[C@@H](Cc1ccccc1)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C29H28ClFN6O4/c30-20-10-11-23(31)22(14-20)19-8-6-18(7-9-19)12-21(34-28(39)26-16-33-37-36-26)15-25(29(40)41)35-27(38)24(32)13-17-4-2-1-3-5-17/h1-11,14,16,21,24-25H,12-13,15,32H2,(H,34,39)(H,35,38)(H,40,41)(H,33,36,37)	SYPMBMOPSHYIOG-UHFFFAOYSA-N	300256	US9593110, 57	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300256	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300256&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528972	381615148					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574712	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C23H22ClFN2O6/c1-32-12-15(23(30)31)9-17(26-22(29)20-11-21(28)27-33-20)8-13-2-4-14(5-3-13)18-10-16(24)6-7-19(18)25/h2-7,10-11,15,17H,8-9,12H2,1H3,(H,26,29)(H,27,28)(H,30,31)	DTVJVEGQNYNCOU-UHFFFAOYSA-N	300257	US9593110, 2-5	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300257	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300257&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252320	381615149							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574713	Cc1cnc(o1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C22H20Cl2FN3O4/c1-11-10-27-21(32-11)20(29)28-15(9-19(26)22(30)31)6-13-3-2-12(7-17(13)24)16-8-14(23)4-5-18(16)25/h2-5,7-8,10,15,19H,6,9,26H2,1H3,(H,28,29)(H,30,31)	LAAXTGVUVLNARM-UHFFFAOYSA-N	300258	US9593110, 18-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300258	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300258&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252470	381615150							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574714	OC(=O)[C@@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnn[nH]1)C1CCOCC1	InChI=1S/C25H28N4O4/c30-24(23-16-26-29-28-23)27-21(15-22(25(31)32)20-10-12-33-13-11-20)14-17-6-8-19(9-7-17)18-4-2-1-3-5-18/h1-9,16,20-22H,10-15H2,(H,27,30)(H,31,32)(H,26,28,29)	RCKGVCILEMQVRA-UHFFFAOYSA-N	300259	US9593110, 58	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300259	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300259&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528973	381615151							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574715	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(OC)no1)C(O)=O	InChI=1S/C24H24ClFN2O6/c1-32-13-16(24(30)31)10-18(27-23(29)21-12-22(33-2)28-34-21)9-14-3-5-15(6-4-14)19-11-17(25)7-8-20(19)26/h3-8,11-12,16,18H,9-10,13H2,1-2H3,(H,27,29)(H,30,31)	KMHWBUBBCJBMCC-UHFFFAOYSA-N	300260	US9593110, 2-6	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300260	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300260&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252269	381615152							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574716	Cc1cnc(o1)C(=O)N[C@@H](C[C@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C22H20Cl2FN3O4/c1-11-10-27-21(32-11)20(29)28-15(9-19(26)22(30)31)6-13-3-2-12(7-17(13)24)16-8-14(23)4-5-18(16)25/h2-5,7-8,10,15,19H,6,9,26H2,1H3,(H,28,29)(H,30,31)	LAAXTGVUVLNARM-UHFFFAOYSA-N	300261	US9593110, 18-4	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300261	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300261&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252386	381615153							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574717	OC(=O)[C@@H](CC(Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C1CCNCC1	InChI=1S/C25H27ClFN5O3/c26-18-5-6-22(27)20(12-18)16-3-1-15(2-4-16)11-19(30-24(33)23-14-29-32-31-23)13-21(25(34)35)17-7-9-28-10-8-17/h1-6,12,14,17,19,21,28H,7-11,13H2,(H,30,33)(H,34,35)(H,29,31,32)	NBABWQSLRACRLV-UHFFFAOYSA-N	300262	US9593110, 59	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300262	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300262&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252391	381615154							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574718	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncco1)C(O)=O	InChI=1S/C23H22ClFN2O5/c1-31-13-16(23(29)30)11-18(27-21(28)22-26-8-9-32-22)10-14-2-4-15(5-3-14)19-12-17(24)6-7-20(19)25/h2-9,12,16,18H,10-11,13H2,1H3,(H,27,28)(H,29,30)	FWPVGSZXWACPLB-UHFFFAOYSA-N	300263	US9593110, 2-7	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300263	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300263&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252325	381615155							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574719	CCc1cc(on1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C23H22Cl2FN3O4/c1-2-15-11-21(33-29-15)22(30)28-16(10-20(27)23(31)32)7-13-4-3-12(8-18(13)25)17-9-14(24)5-6-19(17)26/h3-6,8-9,11,16,20H,2,7,10,27H2,1H3,(H,28,30)(H,31,32)	ZSCUQJUDULCYRF-UHFFFAOYSA-N	300264	US9593110, 18-5	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300264	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300264&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252248	381615156							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574720	CC(=O)N1CCC(CC1)[C@H](CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C27H31N5O4/c1-18(33)32-13-11-22(12-14-32)24(27(35)36)16-23(29-26(34)25-17-28-31-30-25)15-19-7-9-21(10-8-19)20-5-3-2-4-6-20/h2-10,17,22-24H,11-16H2,1H3,(H,29,34)(H,35,36)(H,28,30,31)	RQVAJETUOXOVNK-UHFFFAOYSA-N	300265	US9593110, 60	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300265	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300265&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252279	381615157							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574721	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cocn1)C(O)=O	InChI=1S/C23H22ClFN2O5/c1-31-11-16(23(29)30)9-18(27-22(28)21-12-32-13-26-21)8-14-2-4-15(5-3-14)19-10-17(24)6-7-20(19)25/h2-7,10,12-13,16,18H,8-9,11H2,1H3,(H,27,28)(H,29,30)	OIWZKJIFMOGBCD-UHFFFAOYSA-N	300266	US9593110, 2-8	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300266	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300266&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252340	381615158							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574722	CCc1cc(on1)C(=O)N[C@@H](C[C@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C23H22Cl2FN3O4/c1-2-15-11-21(33-29-15)22(30)28-16(10-20(27)23(31)32)7-13-4-3-12(8-18(13)25)17-9-14(24)5-6-19(17)26/h3-6,8-9,11,16,20H,2,7,10,27H2,1H3,(H,28,30)(H,31,32)	ZSCUQJUDULCYRF-UHFFFAOYSA-N	300267	US9593110, 18-6	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300267	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300267&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252369	381615159							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574723	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(n1)C1CC1)C(O)=O	InChI=1S/C26H26ClFN2O5/c1-34-13-18(26(32)33)11-20(29-24(31)23-14-35-25(30-23)17-6-7-17)10-15-2-4-16(5-3-15)21-12-19(27)8-9-22(21)28/h2-5,8-9,12,14,17-18,20H,6-7,10-11,13H2,1H3,(H,29,31)(H,32,33)	QREWRMBNXJUQIW-UHFFFAOYSA-N	300268	US9593110, 2-9	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300268	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300268&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252464	381615160							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574724	COCc1cc(no1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C23H22Cl2FN3O5/c1-33-11-16-10-21(29-34-16)22(30)28-15(9-20(27)23(31)32)6-13-3-2-12(7-18(13)25)17-8-14(24)4-5-19(17)26/h2-5,7-8,10,15,20H,6,9,11,27H2,1H3,(H,28,30)(H,31,32)	GWUNCOACJXSIDY-UHFFFAOYSA-N	300269	US9593110, 18-7	Neprilysin	Human	 21								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300269	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300269&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252230	381615161							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574725	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]c(=O)o1)C(O)=O	InChI=1S/C23H22ClFN2O6/c1-32-12-15(22(29)30)9-17(27-21(28)20-11-26-23(31)33-20)8-13-2-4-14(5-3-13)18-10-16(24)6-7-19(18)25/h2-7,10-11,15,17H,8-9,12H2,1H3,(H,26,31)(H,27,28)(H,29,30)	YRZILIULHWTVFR-UHFFFAOYSA-N	300270	US9593110, 2-10	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300270	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300270&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252377	381615162							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574726	COCc1cc(no1)C(=O)N[C@@H](C[C@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C23H22Cl2FN3O5/c1-33-11-16-10-21(29-34-16)22(30)28-15(9-20(27)23(31)32)6-13-3-2-12(7-18(13)25)17-8-14(24)4-5-19(17)26/h2-5,7-8,10,15,20H,6,9,11,27H2,1H3,(H,28,30)(H,31,32)	GWUNCOACJXSIDY-UHFFFAOYSA-N	300271	US9593110, 18-8	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300271	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300271&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252496	381615163							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574727	OC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)Cn1ccnc1	InChI=1S/C24H22ClFN6O3/c25-18-5-6-21(26)20(11-18)16-3-1-15(2-4-16)9-19(29-23(33)22-12-28-31-30-22)10-17(24(34)35)13-32-8-7-27-14-32/h1-8,11-12,14,17,19H,9-10,13H2,(H,29,33)(H,34,35)(H,28,30,31)	BJJKOBMIYJVTKZ-UHFFFAOYSA-N	300272	US9593110, 62	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300272	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300272&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252303	381615164							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574728	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C22H21ClFN3O6/c1-32-11-14(21(29)30)9-16(25-20(28)19-26-22(31)33-27-19)8-12-2-4-13(5-3-12)17-10-15(23)6-7-18(17)24/h2-7,10,14,16H,8-9,11H2,1H3,(H,25,28)(H,29,30)(H,26,27,31)	JORDMXQYFVZUCI-UHFFFAOYSA-N	300273	US9593110, 2-11	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300273	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300273&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528974	381615165							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574729	N[C@H](C[C@@H](Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F)NC(=O)c1cc(on1)C1CC1)C(O)=O	InChI=1S/C24H22Cl2FN3O4/c25-15-5-6-19(27)17(9-15)13-3-4-14(18(26)8-13)7-16(10-20(28)24(32)33)29-23(31)21-11-22(34-30-21)12-1-2-12/h3-6,8-9,11-12,16,20H,1-2,7,10,28H2,(H,29,31)(H,32,33)	ZJPRRURMDRRMKB-UHFFFAOYSA-N	300274	US9593110, 18-9	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300274	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300274&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252297	381615166							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574730	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccc(Cl)cn1)C(O)=O	InChI=1S/C25H23Cl2FN2O4/c1-34-14-17(25(32)33)11-20(30-24(31)23-9-7-19(27)13-29-23)10-15-2-4-16(5-3-15)21-12-18(26)6-8-22(21)28/h2-9,12-13,17,20H,10-11,14H2,1H3,(H,30,31)(H,32,33)	AVQZILBNPZBPHX-UHFFFAOYSA-N	300275	US9593110, 2-12	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300275	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300275&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252237	381615167							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574731	N[C@@H](C[C@@H](Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F)NC(=O)c1cc(on1)C1CC1)C(O)=O	InChI=1S/C24H22Cl2FN3O4/c25-15-5-6-19(27)17(9-15)13-3-4-14(18(26)8-13)7-16(10-20(28)24(32)33)29-23(31)21-11-22(34-30-21)12-1-2-12/h3-6,8-9,11-12,16,20H,1-2,7,10,28H2,(H,29,31)(H,32,33)	ZJPRRURMDRRMKB-UHFFFAOYSA-N	300276	US9593110, 18-10	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300276	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300276&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252351	381615168							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574732	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncccn1)C(O)=O	InChI=1S/C24H23ClFN3O4/c1-33-14-17(24(31)32)12-19(29-23(30)22-27-9-2-10-28-22)11-15-3-5-16(6-4-15)20-13-18(25)7-8-21(20)26/h2-10,13,17,19H,11-12,14H2,1H3,(H,29,30)(H,31,32)	QTJDYTWKLBEVMK-UHFFFAOYSA-N	300277	US9593110, 2-13	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300277	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300277&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252363	381615169							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574733	COc1cnc(o1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C22H20Cl2FN3O5/c1-32-19-10-27-21(33-19)20(29)28-14(9-18(26)22(30)31)6-12-3-2-11(7-16(12)24)15-8-13(23)4-5-17(15)25/h2-5,7-8,10,14,18H,6,9,26H2,1H3,(H,28,29)(H,30,31)	VEKSSJZDSFZQAO-UHFFFAOYSA-N	300278	US9593110, 18-11	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300278	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300278&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252264	381615170							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574734	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccc(cn1)C(F)(F)F)C(O)=O	InChI=1S/C26H23ClF4N2O4/c1-37-14-17(25(35)36)11-20(33-24(34)23-9-6-18(13-32-23)26(29,30)31)10-15-2-4-16(5-3-15)21-12-19(27)7-8-22(21)28/h2-9,12-13,17,20H,10-11,14H2,1H3,(H,33,34)(H,35,36)	YVQDONHLOZXBSO-UHFFFAOYSA-N	300279	US9593110, 2-14	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300279	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300279&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252444	381615171							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574735	COc1cnc(o1)C(=O)N[C@@H](C[C@H](N)C(O)=O)Cc1ccc(cc1Cl)-c1cc(Cl)ccc1F	InChI=1S/C22H20Cl2FN3O5/c1-32-19-10-27-21(33-19)20(29)28-14(9-18(26)22(30)31)6-12-3-2-11(7-16(12)24)15-8-13(23)4-5-17(15)25/h2-5,7-8,10,14,18H,6,9,26H2,1H3,(H,28,29)(H,30,31)	VEKSSJZDSFZQAO-UHFFFAOYSA-N	300280	US9593110, 18-12	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300280	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300280&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252413	381615172							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574736	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncc(C)o1)C(O)=O	InChI=1S/C24H24ClFN2O5/c1-14-12-27-23(33-14)22(29)28-19(10-17(13-32-2)24(30)31)9-15-3-5-16(6-4-15)20-11-18(25)7-8-21(20)26/h3-8,11-12,17,19H,9-10,13H2,1-2H3,(H,28,29)(H,30,31)	VIPAZHQHKGUKTB-UHFFFAOYSA-N	300281	US9593110, 2-15	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300281	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300281&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252257	381615173							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574737	CCOc1cc(n[nH]1)C(=O)N[C@@H](C[C@@H](COC)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C25H27ClFN3O5/c1-3-35-23-13-22(29-30-23)24(31)28-19(11-17(14-34-2)25(32)33)10-15-4-6-16(7-5-15)20-12-18(26)8-9-21(20)27/h4-9,12-13,17,19H,3,10-11,14H2,1-2H3,(H,28,31)(H,29,30)(H,32,33)	VRSZEFJCNXIZHU-UHFFFAOYSA-N	300282	US9593110, 2-16	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300282	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300282&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252478	381615174							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574738	CCc1cc(on1)C(=O)N[C@@H](C[C@@H](CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H25ClFN3O4/c1-2-18-12-22(33-29-18)23(30)28-19(10-16(13-27)24(31)32)9-14-3-5-15(6-4-14)20-11-17(25)7-8-21(20)26/h3-8,11-12,16,19H,2,9-10,13,27H2,1H3,(H,28,30)(H,31,32)	DAVPYHSEGTZBTG-UHFFFAOYSA-N	300283	US9593110, 21-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300283	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300283&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252360	381615175							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574739	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1n[nH]c(n1)C(F)(F)F)C(O)=O	InChI=1S/C23H22ClF3N4O4/c1-35-12-16(21(33)34)11-18(28-20(32)19-29-22(31-30-19)23(25,26)27)9-13-5-7-14(8-6-13)15-3-2-4-17(24)10-15/h2-8,10,16,18H,9,11-12H2,1H3,(H,28,32)(H,33,34)(H,29,30,31)	WUANUHXPULBICT-UHFFFAOYSA-N	300284	US9593110, 4-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300284	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300284&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252215	381615176							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574740	NC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(n1)C1CC1)C(O)=O	InChI=1S/C25H25ClFN3O4/c26-18-7-8-21(27)20(11-18)15-3-1-14(2-4-15)9-19(10-17(12-28)25(32)33)29-23(31)22-13-34-24(30-22)16-5-6-16/h1-4,7-8,11,13,16-17,19H,5-6,9-10,12,28H2,(H,29,31)(H,32,33)	CBTVGQLBGPMHJP-UHFFFAOYSA-N	300285	US9593110, 21-2	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300285	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300285&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252488	381615177							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574741	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C23H23ClN2O6/c1-31-13-17(23(29)30)11-19(25-22(28)20-12-21(27)26-32-20)9-14-5-7-15(8-6-14)16-3-2-4-18(24)10-16/h2-8,10,12,17,19H,9,11,13H2,1H3,(H,25,28)(H,26,27)(H,29,30)	SKSTWLJFLPHKRZ-UHFFFAOYSA-N	300286	US9593110, 4-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300286	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300286&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252259	381615178							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574742	Cc1cnc(o1)C(=O)N[C@@H](C[C@@H](CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN3O4/c1-13-12-27-22(32-13)21(29)28-18(9-16(11-26)23(30)31)8-14-2-4-15(5-3-14)19-10-17(24)6-7-20(19)25/h2-7,10,12,16,18H,8-9,11,26H2,1H3,(H,28,29)(H,30,31)	ZZCWVSQGCVQXBE-UHFFFAOYSA-N	300287	US9593110, 21-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300287	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300287&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252480	381615179							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574743	COC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C22H22ClN3O6/c1-31-12-16(21(28)29)11-18(24-20(27)19-25-22(30)32-26-19)9-13-5-7-14(8-6-13)15-3-2-4-17(23)10-15/h2-8,10,16,18H,9,11-12H2,1H3,(H,24,27)(H,28,29)(H,25,26,30)	MOGGEEHAIZFGOU-UHFFFAOYSA-N	300288	US9593110, 4-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300288	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300288&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528975	381615180							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574744	CCOc1nc(co1)C(=O)N[C@@H](C[C@@H](CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H25ClFN3O5/c1-2-33-24-29-21(13-34-24)22(30)28-18(10-16(12-27)23(31)32)9-14-3-5-15(6-4-14)19-11-17(25)7-8-20(19)26/h3-8,11,13,16,18H,2,9-10,12,27H2,1H3,(H,28,30)(H,31,32)	MVGJLMOVCOEWSO-UHFFFAOYSA-N	300289	US9593110, 21-4	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300289	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300289&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252476	381615181							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574745	Cc1nc(co1)C(=O)N[C@@H](C[C@@H](CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN3O4/c1-13-27-21(12-32-13)22(29)28-18(9-16(11-26)23(30)31)8-14-2-4-15(5-3-14)19-10-17(24)6-7-20(19)25/h2-7,10,12,16,18H,8-9,11,26H2,1H3,(H,28,29)(H,30,31)	XLULDPUQAYYWLK-UHFFFAOYSA-N	300290	US9593110, 21-5	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300290	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300290&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252372	381615182							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574746	Cc1cc(sn1)C(=O)N[C@@H](C[C@@H](CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN3O3S/c1-13-8-21(32-28-13)22(29)27-18(10-16(12-26)23(30)31)9-14-2-4-15(5-3-14)19-11-17(24)6-7-20(19)25/h2-8,11,16,18H,9-10,12,26H2,1H3,(H,27,29)(H,30,31)	AZADHFUFSZWDOS-UHFFFAOYSA-N	300291	US9593110, 21-6	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300291	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300291&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252268	381615183							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574747	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C23H24ClFN4O4/c1-2-33-13-16(23(31)32)10-18(27-22(30)21-12-26-29-28-21)9-14-3-5-15(6-4-14)19-11-17(24)7-8-20(19)25/h3-8,11-12,16,18H,2,9-10,13H2,1H3,(H,27,30)(H,31,32)(H,26,28,29)	AABIHRPKNRHYNW-UHFFFAOYSA-N	300292	US9593110, 7-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300292	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300292&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252408	381615184							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574748	NC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnsc1)C(O)=O	InChI=1S/C22H21ClFN3O3S/c23-17-5-6-20(24)19(9-17)14-3-1-13(2-4-14)7-18(8-15(10-25)22(29)30)27-21(28)16-11-26-31-12-16/h1-6,9,11-12,15,18H,7-8,10,25H2,(H,27,28)(H,29,30)	HUVUPCGQIRERPJ-UHFFFAOYSA-N	300293	US9593110, 21-7	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300293	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300293&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252304	381615185							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574749	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1[nH]nc(C2CC2)c1F)C(O)=O	InChI=1S/C27H28ClF2N3O4/c1-2-37-14-18(27(35)36)12-20(31-26(34)25-23(30)24(32-33-25)17-7-8-17)11-15-3-5-16(6-4-15)21-13-19(28)9-10-22(21)29/h3-6,9-10,13,17-18,20H,2,7-8,11-12,14H2,1H3,(H,31,34)(H,32,33)(H,35,36)	RQCNZKAATWTZTF-UHFFFAOYSA-N	300294	US9593110, 7-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300294	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300294&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252410	381615186							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574750	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(n[nH]1)C(C)=O)C(O)=O	InChI=1S/C26H27ClFN3O5/c1-3-36-14-18(26(34)35)11-20(29-25(33)24-13-23(15(2)32)30-31-24)10-16-4-6-17(7-5-16)21-12-19(27)8-9-22(21)28/h4-9,12-13,18,20H,3,10-11,14H2,1-2H3,(H,29,33)(H,30,31)(H,34,35)	UQMPEAUJHZKAQW-UHFFFAOYSA-N	300295	US9593110, 7-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300295	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300295&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528976	381615187							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574751	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C24H24ClFN2O6/c1-2-33-13-16(24(31)32)10-18(27-23(30)21-12-22(29)28-34-21)9-14-3-5-15(6-4-14)19-11-17(25)7-8-20(19)26/h3-8,11-12,16,18H,2,9-10,13H2,1H3,(H,27,30)(H,28,29)(H,31,32)	KVEPVGVRSPLXLR-UHFFFAOYSA-N	300296	US9593110, 7-4	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300296	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300296&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252271	381615188							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574752	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(CC)no1)C(O)=O	InChI=1S/C26H28ClFN2O5/c1-3-20-14-24(35-30-20)25(31)29-21(12-18(26(32)33)15-34-4-2)11-16-5-7-17(8-6-16)22-13-19(27)9-10-23(22)28/h5-10,13-14,18,21H,3-4,11-12,15H2,1-2H3,(H,29,31)(H,32,33)	XDZUPNQPMIKICG-UHFFFAOYSA-N	300297	US9593110, 7-5	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300297	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300297&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252438	381615189							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574753	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncco1)C(O)=O	InChI=1S/C24H24ClFN2O5/c1-2-32-14-17(24(30)31)12-19(28-22(29)23-27-9-10-33-23)11-15-3-5-16(6-4-15)20-13-18(25)7-8-21(20)26/h3-10,13,17,19H,2,11-12,14H2,1H3,(H,28,29)(H,30,31)	PGCQEKNKHOYAGG-UHFFFAOYSA-N	300298	US9593110, 7-6	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300298	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300298&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252375	381615190							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574754	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cocn1)C(O)=O	InChI=1S/C24H24ClFN2O5/c1-2-32-12-17(24(30)31)10-19(28-23(29)22-13-33-14-27-22)9-15-3-5-16(6-4-15)20-11-18(25)7-8-21(20)26/h3-8,11,13-14,17,19H,2,9-10,12H2,1H3,(H,28,29)(H,30,31)	DJWMFYKXKWQFPK-UHFFFAOYSA-N	300299	US9593110, 7-7	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300299	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300299&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252367	381615191							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574755	CC(C)c1coc(n1)C(=O)N[C@@H](C[C@@H](CCN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C26H29ClFN3O4/c1-15(2)23-14-35-25(31-23)24(32)30-20(12-18(9-10-29)26(33)34)11-16-3-5-17(6-4-16)21-13-19(27)7-8-22(21)28/h3-8,13-15,18,20H,9-12,29H2,1-2H3,(H,30,32)(H,33,34)	NHTBQRNGIWDXTQ-UHFFFAOYSA-N	300300	US9593110, 24-1	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300300	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300300&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252336	381615192							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574756	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(n1)C1CC1)C(O)=O	InChI=1S/C27H28ClFN2O5/c1-2-35-14-19(27(33)34)12-21(30-25(32)24-15-36-26(31-24)18-7-8-18)11-16-3-5-17(6-4-16)22-13-20(28)9-10-23(22)29/h3-6,9-10,13,15,18-19,21H,2,7-8,11-12,14H2,1H3,(H,30,32)(H,33,34)	SJHHOSHKFIMGHJ-UHFFFAOYSA-N	300301	US9593110, 7-8	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300301	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300301&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252459	381615193							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574757	NCC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C22H23ClFN5O3/c23-16-5-6-19(24)18(11-16)14-3-1-13(2-4-14)9-17(10-15(7-8-25)22(31)32)27-21(30)20-12-26-29-28-20/h1-6,11-12,15,17H,7-10,25H2,(H,27,30)(H,31,32)(H,26,28,29)	HQYKZPAMQZFDED-UHFFFAOYSA-N	300302	US9593110, 24-2	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300302	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300302&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252231	381615194							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574758	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]c(=O)o1)C(O)=O	InChI=1S/C24H24ClFN2O6/c1-2-33-13-16(23(30)31)10-18(28-22(29)21-12-27-24(32)34-21)9-14-3-5-15(6-4-14)19-11-17(25)7-8-20(19)26/h3-8,11-12,16,18H,2,9-10,13H2,1H3,(H,27,32)(H,28,29)(H,30,31)	DHQBELNKANGSMO-UHFFFAOYSA-N	300303	US9593110, 7-9	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300303	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300303&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252362	381615195							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574759	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C23H23ClFN3O6/c1-2-33-12-15(22(30)31)10-17(26-21(29)20-27-23(32)34-28-20)9-13-3-5-14(6-4-13)18-11-16(24)7-8-19(18)25/h3-8,11,15,17H,2,9-10,12H2,1H3,(H,26,29)(H,30,31)(H,27,28,32)	KBLOJOJIUPCBNX-UHFFFAOYSA-N	300304	US9593110, 7-10	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300304	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300304&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528977	381615196							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574760	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncccn1)C(O)=O	InChI=1S/C25H25ClFN3O4/c1-2-34-15-18(25(32)33)13-20(30-24(31)23-28-10-3-11-29-23)12-16-4-6-17(7-5-16)21-14-19(26)8-9-22(21)27/h3-11,14,18,20H,2,12-13,15H2,1H3,(H,30,31)(H,32,33)	WZJFLGUUZOSDMS-UHFFFAOYSA-N	300305	US9593110, 7-11	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300305	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300305&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252276	381615197							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574761	CCC(=O)N[C@H](C[C@@H](Cc2ccc(c1ccccc1)cc2)NC(=O)C3CNN=N3)C(=O)O	InChI=1S/C23H25N5O4/c1-2-21(29)26-19(23(31)32)13-18(25-22(30)20-14-24-28-27-20)12-15-8-10-17(11-9-15)16-6-4-3-5-7-16/h3-11,14,18-19H,2,12-13H2,1H3,(H,25,30)(H,26,29)(H,31,32)(H,24,27,28)	IUIVYFZIKQTEAE-UHFFFAOYSA-N	300306	US9593110, Example 27	Neprilysin	Homo sapiens	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300306	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300306&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255210	381615198							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574762	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C23H25ClN4O4/c1-2-32-14-18(23(30)31)12-20(26-22(29)21-13-25-28-27-21)10-15-6-8-16(9-7-15)17-4-3-5-19(24)11-17/h3-9,11,13,18,20H,2,10,12,14H2,1H3,(H,26,29)(H,30,31)(H,25,27,28)	ZNTARUJDWDFDSO-UHFFFAOYSA-N	300307	US9593110, 9-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300307	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300307&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252439	381615199							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574763	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc([nH]n1)C(C)=O)C(O)=O	InChI=1S/C26H28ClN3O5/c1-3-35-15-20(26(33)34)13-22(28-25(32)24-14-23(16(2)31)29-30-24)11-17-7-9-18(10-8-17)19-5-4-6-21(27)12-19/h4-10,12,14,20,22H,3,11,13,15H2,1-2H3,(H,28,32)(H,29,30)(H,33,34)	BXIGWMGSMQTYOE-UHFFFAOYSA-N	300308	US9593110, 9-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300308	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300308&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528979	381615200							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574764	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C22H21ClFN5O5/c1-34-22(33)27-18(21(31)32)10-15(26-20(30)19-11-25-29-28-19)8-12-2-4-13(5-3-12)16-9-14(23)6-7-17(16)24/h2-7,9,11,15,18H,8,10H2,1H3,(H,26,30)(H,27,33)(H,31,32)(H,25,28,29)	MVFFGJWGKSLMHV-UHFFFAOYSA-N	300309	US9593110, 30-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300309	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300309&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252434	381615201							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574765	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1n[nH]c(n1)C(F)(F)F)C(O)=O	InChI=1S/C24H24ClF3N4O4/c1-2-36-13-17(22(34)35)12-19(29-21(33)20-30-23(32-31-20)24(26,27)28)10-14-6-8-15(9-7-14)16-4-3-5-18(25)11-16/h3-9,11,17,19H,2,10,12-13H2,1H3,(H,29,33)(H,34,35)(H,30,31,32)	IMBCZCITOMFFPP-UHFFFAOYSA-N	300310	US9593110, 9-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300310	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300310&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252278	381615202							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574766	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(n[nH]1)C(C)=O)C(O)=O	InChI=1S/C25H24ClFN4O6/c1-13(32)20-12-21(31-30-20)23(33)28-17(11-22(24(34)35)29-25(36)37-2)9-14-3-5-15(6-4-14)18-10-16(26)7-8-19(18)27/h3-8,10,12,17,22H,9,11H2,1-2H3,(H,28,33)(H,29,36)(H,30,31)(H,34,35)	GBTNYCPKOFKDSQ-UHFFFAOYSA-N	300311	US9593110, 30-2	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300311	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300311&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528980	381615203							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574767	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1cc(OC)no1)C(O)=O	InChI=1S/C25H27ClN2O6/c1-3-33-15-19(25(30)31)13-21(27-24(29)22-14-23(32-2)28-34-22)11-16-7-9-17(10-8-16)18-5-4-6-20(26)12-18/h4-10,12,14,19,21H,3,11,13,15H2,1-2H3,(H,27,29)(H,30,31)	WWEBQPPZXRJSMW-UHFFFAOYSA-N	300312	US9593110, 9-4	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300312	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300312&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252371	381615204							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574768	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncco1)C(O)=O	InChI=1S/C23H21ClFN3O6/c1-33-23(32)28-19(22(30)31)12-16(27-20(29)21-26-8-9-34-21)10-13-2-4-14(5-3-13)17-11-15(24)6-7-18(17)25/h2-9,11,16,19H,10,12H2,1H3,(H,27,29)(H,28,32)(H,30,31)	QFNRQSGGSMYIRG-UHFFFAOYSA-N	300313	US9593110, 30-3	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300313	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300313&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			126654098	381615205							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574769	CCOC[C@H](C[C@@H](Cc1ccc(cc1)-c1cccc(Cl)c1)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C23H24ClN3O6/c1-2-32-13-17(22(29)30)12-19(25-21(28)20-26-23(31)33-27-20)10-14-6-8-15(9-7-14)16-4-3-5-18(24)11-16/h3-9,11,17,19H,2,10,12-13H2,1H3,(H,25,28)(H,29,30)(H,26,27,31)	QKOQUTFIDIMUEL-UHFFFAOYSA-N	300314	US9593110, 9-5	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300314	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300314&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528981	381615206							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574770	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncc(C)o1)C(O)=O	InChI=1S/C24H23ClFN3O6/c1-13-12-27-22(35-13)21(30)28-17(11-20(23(31)32)29-24(33)34-2)9-14-3-5-15(6-4-14)18-10-16(25)7-8-19(18)26/h3-8,10,12,17,20H,9,11H2,1-2H3,(H,28,30)(H,29,33)(H,31,32)	SNJWDFUOBVKKQS-UHFFFAOYSA-N	300315	US9593110, 30-4	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300315	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300315&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252497	381615207							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574771	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(n1)C1CC1)C(O)=O	InChI=1S/C26H25ClFN3O6/c1-36-26(35)31-21(25(33)34)12-18(29-23(32)22-13-37-24(30-22)16-6-7-16)10-14-2-4-15(5-3-14)19-11-17(27)8-9-20(19)28/h2-5,8-9,11,13,16,18,21H,6-7,10,12H2,1H3,(H,29,32)(H,31,35)(H,33,34)	VNUPWNPAPSHZQR-UHFFFAOYSA-N	300316	US9593110, 30-5	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300316	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300316&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252292	381615208							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574772	CCc1nc(co1)C(=O)N[C@@H](C[C@@H](NC(=O)OC)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C25H25ClFN3O6/c1-3-22-29-21(13-36-22)23(31)28-17(12-20(24(32)33)30-25(34)35-2)10-14-4-6-15(7-5-14)18-11-16(26)8-9-19(18)27/h4-9,11,13,17,20H,3,10,12H2,1-2H3,(H,28,31)(H,30,34)(H,32,33)	SHRJUJSTIJJWJS-UHFFFAOYSA-N	300317	US9593110, 30-6	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300317	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300317&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252390	381615209							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574773	CCOc1nc(co1)C(=O)N[C@@H](C[C@@H](NC(=O)OC)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C25H25ClFN3O7/c1-3-36-25-30-21(13-37-25)22(31)28-17(12-20(23(32)33)29-24(34)35-2)10-14-4-6-15(7-5-14)18-11-16(26)8-9-19(18)27/h4-9,11,13,17,20H,3,10,12H2,1-2H3,(H,28,31)(H,29,34)(H,32,33)	AUIPEKCLFDOGQQ-UHFFFAOYSA-N	300318	US9593110, 30-7	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300318	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300318&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252406	381615210							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574774	CCOc1oc(nc1C)C(=O)N[C@@H](C[C@@H](NC(=O)OC)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C26H27ClFN3O7/c1-4-37-25-14(2)29-23(38-25)22(32)30-18(13-21(24(33)34)31-26(35)36-3)11-15-5-7-16(8-6-15)19-12-17(27)9-10-20(19)28/h5-10,12,18,21H,4,11,13H2,1-3H3,(H,30,32)(H,31,35)(H,33,34)	BTBJVTUNTKUURT-UHFFFAOYSA-N	300319	US9593110, 30-8	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300319	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300319&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252440	381615211							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574775	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C22H20ClFN4O7/c1-34-21(32)26-17(20(30)31)10-14(25-19(29)18-27-22(33)35-28-18)8-11-2-4-12(5-3-11)15-9-13(23)6-7-16(15)24/h2-7,9,14,17H,8,10H2,1H3,(H,25,29)(H,26,32)(H,30,31)(H,27,28,33)	OZOIOZWTSATOOY-UHFFFAOYSA-N	300320	US9593110, 30-9	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300320	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300320&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528982	381615212							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574776	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1c[nH]c(=O)o1)C(O)=O	InChI=1S/C23H21ClFN3O7/c1-34-23(33)28-18(21(30)31)10-15(27-20(29)19-11-26-22(32)35-19)8-12-2-4-13(5-3-12)16-9-14(24)6-7-17(16)25/h2-7,9,11,15,18H,8,10H2,1H3,(H,26,32)(H,27,29)(H,28,33)(H,30,31)	ODRLQXVHSHWQNP-UHFFFAOYSA-N	300321	US9593110, 30-10	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300321	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300321&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252494	381615213							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574777	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(=O)[nH]1)C(O)=O	InChI=1S/C23H21ClFN3O7/c1-34-22(32)27-18(21(30)31)10-15(26-20(29)19-11-35-23(33)28-19)8-12-2-4-13(5-3-12)16-9-14(24)6-7-17(16)25/h2-7,9,11,15,18H,8,10H2,1H3,(H,26,29)(H,27,32)(H,28,33)(H,30,31)	OXQUSOHTFJEMTD-UHFFFAOYSA-N	300322	US9593110, 30-11	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300322	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300322&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252396	381615214							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574778	CCc1cc(on1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN3O4/c1-2-16-12-21(32-28-16)22(29)27-17(11-20(26)23(30)31)9-13-3-5-14(6-4-13)18-10-15(24)7-8-19(18)25/h3-8,10,12,17,20H,2,9,11,26H2,1H3,(H,27,29)(H,30,31)	YNZAHGAIEGELDT-UHFFFAOYSA-N	300323	US9593110, 16-1	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300323	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300323&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252316	381615215							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574779	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccc(Cl)cn1)C(O)=O	InChI=1S/C25H22Cl2FN3O5/c1-36-25(35)31-22(24(33)34)12-18(30-23(32)21-9-7-17(27)13-29-21)10-14-2-4-15(5-3-14)19-11-16(26)6-8-20(19)28/h2-9,11,13,18,22H,10,12H2,1H3,(H,30,32)(H,31,35)(H,33,34)	OWYDKGYZPFHQFY-UHFFFAOYSA-N	300324	US9593110, 30-12	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300324	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300324&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252491	381615216							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574780	CCCc1cc(no1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H25ClFN3O4/c1-2-3-18-13-22(29-33-18)23(30)28-17(12-21(27)24(31)32)10-14-4-6-15(7-5-14)19-11-16(25)8-9-20(19)26/h4-9,11,13,17,21H,2-3,10,12,27H2,1H3,(H,28,30)(H,31,32)	XTNCUPXHHZYNRX-UHFFFAOYSA-N	300325	US9593110, 16-2	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300325	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300325&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252453	381615217							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574781	COC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C22H23N5O5/c1-32-22(31)25-18(21(29)30)12-17(24-20(28)19-13-23-27-26-19)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,13,17-18H,11-12H2,1H3,(H,24,28)(H,25,31)(H,29,30)(H,23,26,27)	SOOCDFKGRBYQIK-UHFFFAOYSA-N	300326	US9593110, 31	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300326	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300326&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528983	381615218							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574782	Cc1cnc(o1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C22H21ClFN3O4/c1-12-11-26-21(31-12)20(28)27-16(10-19(25)22(29)30)8-13-2-4-14(5-3-13)17-9-15(23)6-7-18(17)24/h2-7,9,11,16,19H,8,10,25H2,1H3,(H,27,28)(H,29,30)	AGQLXIPPEKMOCP-UHFFFAOYSA-N	300327	US9593110, 16-3	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300327	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300327&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252267	381615219							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574783	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(n1)C1CC1)C(O)=O	InChI=1S/C24H23ClFN3O4/c25-16-7-8-19(26)18(10-16)14-3-1-13(2-4-14)9-17(11-20(27)24(31)32)28-22(30)21-12-33-23(29-21)15-5-6-15/h1-4,7-8,10,12,15,17,20H,5-6,9,11,27H2,(H,28,30)(H,31,32)	BVKHCPDYZISTBZ-UHFFFAOYSA-N	300328	US9593110, 16-4	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300328	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300328&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252404	381615220							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574784	CCOc1nc(co1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN3O5/c1-2-32-23-28-20(12-33-23)21(29)27-16(11-19(26)22(30)31)9-13-3-5-14(6-4-13)17-10-15(24)7-8-18(17)25/h3-8,10,12,16,19H,2,9,11,26H2,1H3,(H,27,29)(H,30,31)	KXYBDLUJKZJEOQ-UHFFFAOYSA-N	300329	US9593110, 16-5	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300329	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300329&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252468	381615221							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574785	CC(C)c1coc(n1)C(=O)N[C@@H](C[C@@H](NC(=O)CN)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C26H28ClFN4O5/c1-14(2)22-13-37-25(32-22)24(34)30-18(11-21(26(35)36)31-23(33)12-29)9-15-3-5-16(6-4-15)19-10-17(27)7-8-20(19)28/h3-8,10,13-14,18,21H,9,11-12,29H2,1-2H3,(H,30,34)(H,31,33)(H,35,36)	IJWKKSYVKJQRNB-UHFFFAOYSA-N	300330	US9593110, 34-1	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300330	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300330&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252424	381615222							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574786	CCCc1nc(co1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H25ClFN3O4/c1-2-3-22-29-21(13-33-22)23(30)28-17(12-20(27)24(31)32)10-14-4-6-15(7-5-14)18-11-16(25)8-9-19(18)26/h4-9,11,13,17,20H,2-3,10,12,27H2,1H3,(H,28,30)(H,31,32)	VDTTYZLMOYJNNT-UHFFFAOYSA-N	300331	US9593110, 16-6	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300331	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300331&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252364	381615223							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574787	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccc(Cl)cn1)C(O)=O	InChI=1S/C23H20Cl2FN3O3/c24-15-5-7-19(26)18(10-15)14-3-1-13(2-4-14)9-17(11-20(27)23(31)32)29-22(30)21-8-6-16(25)12-28-21/h1-8,10,12,17,20H,9,11,27H2,(H,29,30)(H,31,32)	MADZMYDLMNRCRZ-UHFFFAOYSA-N	300332	US9593110, 16-7	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300332	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300332&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252499	381615224							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574788	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ccns1)C(O)=O	InChI=1S/C21H19ClFN3O3S/c22-14-5-6-17(23)16(10-14)13-3-1-12(2-4-13)9-15(11-18(24)21(28)29)26-20(27)19-7-8-25-30-19/h1-8,10,15,18H,9,11,24H2,(H,26,27)(H,28,29)	XGKRAPGYVJBTNK-UHFFFAOYSA-N	300333	US9593110, 16-8	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300333	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300333&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252290	381615225							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574789	CC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H22ClFN4O4/c1-12(30)20-11-21(29-28-20)22(31)27-16(10-19(26)23(32)33)8-13-2-4-14(5-3-13)17-9-15(24)6-7-18(17)25/h2-7,9,11,16,19H,8,10,26H2,1H3,(H,27,31)(H,28,29)(H,32,33)	NVBJMTZHWDTIIS-UHFFFAOYSA-N	300334	US9593110, 16-9	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300334	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300334&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528984	381615226							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574790	C[C@H](N)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C23H24ClFN6O4/c1-12(26)21(32)29-19(23(34)35)10-16(28-22(33)20-11-27-31-30-20)8-13-2-4-14(5-3-13)17-9-15(24)6-7-18(17)25/h2-7,9,11-12,16,19H,8,10,26H2,1H3,(H,28,33)(H,29,32)(H,34,35)(H,27,30,31)	BJZRQNQFBAVJPL-UHFFFAOYSA-N	300335	US9593110, 37-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300335	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300335&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252484	381615227					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574791	CCOC(=O)[C@H](N)C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(n[nH]1)C(C)=O	InChI=1S/C25H26ClFN4O4/c1-3-35-25(34)21(28)12-18(29-24(33)23-13-22(14(2)32)30-31-23)10-15-4-6-16(7-5-15)19-11-17(26)8-9-20(19)27/h4-9,11,13,18,21H,3,10,12,28H2,1-2H3,(H,29,33)(H,30,31)	BHYUISWIOMZDGL-UHFFFAOYSA-N	300336	US9593110, 16-10	Neprilysin	Human	 21								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300336	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300336&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252495	381615228					C03317		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574792	CCOC(=O)[C@H](N)C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(O)no1	InChI=1S/C23H23ClFN3O5/c1-2-32-23(31)19(26)11-16(27-22(30)20-12-21(29)28-33-20)9-13-3-5-14(6-4-13)17-10-15(24)7-8-18(17)25/h3-8,10,12,16,19H,2,9,11,26H2,1H3,(H,27,30)(H,28,29)	ZUZFGFVHZYJHMJ-UHFFFAOYSA-N	300337	US9593110, 16-11	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300337	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300337&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252344	381615229					C03317		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574793	CC(C)[C@H](N)C(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C25H28ClFN6O4/c1-13(2)22(28)24(35)31-20(25(36)37)11-17(30-23(34)21-12-29-33-32-21)9-14-3-5-15(6-4-14)18-10-16(26)7-8-19(18)27/h3-8,10,12-13,17,20,22H,9,11,28H2,1-2H3,(H,30,34)(H,31,35)(H,36,37)(H,29,32,33)	URHOABGIECTJAG-UHFFFAOYSA-N	300338	US9593110, 39-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300338	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300338&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252399	381615230					C00107		1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574794	NCCC(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C23H24ClFN6O4/c24-15-5-6-18(25)17(10-15)14-3-1-13(2-4-14)9-16(28-22(33)20-12-27-31-30-20)11-19(23(34)35)29-21(32)7-8-26/h1-6,10,12,16,19H,7-9,11,26H2,(H,28,33)(H,29,32)(H,34,35)(H,27,30,31)	OMRHZIVDJMGZRH-UHFFFAOYSA-N	300339	US9593110, 41	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300339	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300339&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252274	381615231							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574795	N[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C20H18ClFN4O5/c21-12-5-6-15(22)14(8-12)11-3-1-10(2-4-11)7-13(9-16(23)19(28)29)24-18(27)17-25-20(30)31-26-17/h1-6,8,13,16H,7,9,23H2,(H,24,27)(H,28,29)(H,25,26,30)	CKPISWBYARRYBJ-UHFFFAOYSA-N	300340	US9593110, 16-15	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300340	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300340&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528985	381615232							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574796	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1noc(=O)[nH]1)C(O)=O	InChI=1S/C20H18ClFN4O5/c21-12-5-6-15(22)14(8-12)11-3-1-10(2-4-11)7-13(9-16(23)19(28)29)24-18(27)17-25-20(30)31-26-17/h1-6,8,13,16H,7,9,23H2,(H,24,27)(H,28,29)(H,25,26,30)	CKPISWBYARRYBJ-UHFFFAOYSA-N	300341	US9593110, 16-16	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300341	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300341&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528986	381615233							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574797	CN(C)C(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H25ClFN5O4/c1-31(2)23(33)21-12-20(29-30-21)22(32)28-16(11-19(27)24(34)35)9-13-3-5-14(6-4-13)17-10-15(25)7-8-18(17)26/h3-8,10,12,16,19H,9,11,27H2,1-2H3,(H,28,32)(H,29,30)(H,34,35)	CTOLZLHGCKTRHX-UHFFFAOYSA-N	300342	US9593110, 16-18	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300342	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300342&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252433	381615234							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574798	NCC(=O)NC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)C(O)=O	InChI=1S/C23H24ClFN6O4/c24-16-5-6-19(25)18(9-16)14-3-1-13(2-4-14)7-17(29-22(33)20-12-28-31-30-20)8-15(23(34)35)11-27-21(32)10-26/h1-6,9,12,15,17H,7-8,10-11,26H2,(H,27,32)(H,29,33)(H,34,35)(H,28,30,31)	AXSWKQGMNQBUHN-UHFFFAOYSA-N	300343	US9593110, 44-1	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300343	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300343&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252452	381615235							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574799	Cc1n[nH]c(C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc2ccc(cc2)-c2cc(Cl)ccc2F)c1F	InChI=1S/C22H21ClF2N4O3/c1-11-19(25)20(29-28-11)21(30)27-15(10-18(26)22(31)32)8-12-2-4-13(5-3-12)16-9-14(23)6-7-17(16)24/h2-7,9,15,18H,8,10,26H2,1H3,(H,27,30)(H,28,29)(H,31,32)	GNLPWMXTXQQLPL-UHFFFAOYSA-N	300344	US9593110, 16-20	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300344	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300344&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252466	381615236							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574800	CNC(=O)c1cc([nH]n1)C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C23H23ClFN5O4/c1-27-21(31)19-11-20(30-29-19)22(32)28-15(10-18(26)23(33)34)8-12-2-4-13(5-3-12)16-9-14(24)6-7-17(16)25/h2-7,9,11,15,18H,8,10,26H2,1H3,(H,27,31)(H,28,32)(H,29,30)(H,33,34)	OMBDPNLUSHBLCI-UHFFFAOYSA-N	300345	US9593110, 16-21	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300345	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300345&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252211	381615237							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574801	CS(=O)(=O)N[C@H](C[C@@H](Cc1ccc(cc1)-c1ccccc1)NC(=O)c1c[nH]nn1)C(O)=O	InChI=1S/C21H23N5O5S/c1-32(30,31)25-18(21(28)29)12-17(23-20(27)19-13-22-26-24-19)11-14-7-9-16(10-8-14)15-5-3-2-4-6-15/h2-10,13,17-18,25H,11-12H2,1H3,(H,23,27)(H,28,29)(H,22,24,26)	DWYYDAGFDARGRH-UHFFFAOYSA-N	300346	US9593110, 47	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300346	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300346&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528987	381615238							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574802	Cc1ccccc1-c1n[nH]c(C(=O)N[C@@H](C[C@@H](N)C(O)=O)Cc2ccc(cc2)-c2cc(Cl)ccc2F)c1F	InChI=1S/C28H25ClF2N4O3/c1-15-4-2-3-5-20(15)25-24(31)26(35-34-25)27(36)33-19(14-23(32)28(37)38)12-16-6-8-17(9-7-16)21-13-18(29)10-11-22(21)30/h2-11,13,19,23H,12,14,32H2,1H3,(H,33,36)(H,34,35)(H,37,38)	GCHSLIKXPJABKK-UHFFFAOYSA-N	300347	US9593110, 16-23	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300347	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300347&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			137528988	381615239							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574803	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(no1)-c1ccccc1Cl)C(O)=O	InChI=1S/C27H22Cl2FN3O4/c28-17-9-10-22(30)20(12-17)16-7-5-15(6-8-16)11-18(13-23(31)27(35)36)32-26(34)25-14-24(33-37-25)19-3-1-2-4-21(19)29/h1-10,12,14,18,23H,11,13,31H2,(H,32,34)(H,35,36)	STESRDYXGDNABU-UHFFFAOYSA-N	300348	US9593110, 16-24	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300348	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300348&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252370	475740363							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574804	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1nc2cc(Cl)ccn2n1)C(O)=O	InChI=1S/C24H20Cl2FN5O3/c25-15-5-6-19(27)18(10-15)14-3-1-13(2-4-14)9-17(12-20(28)24(34)35)29-23(33)22-30-21-11-16(26)7-8-32(21)31-22/h1-8,10-11,17,20H,9,12,28H2,(H,29,33)(H,34,35)	KRZJZRLBSHPMQU-UHFFFAOYSA-N	300349	US9593110, 16-25::BDBM300350	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300349	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300349&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252366	475741916							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574805	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1nc2cc(Cl)ccn2n1)C(O)=O	InChI=1S/C24H20Cl2FN5O3/c25-15-5-6-19(27)18(10-15)14-3-1-13(2-4-14)9-17(12-20(28)24(34)35)29-23(33)22-30-21-11-16(26)7-8-32(21)31-22/h1-8,10-11,17,20H,9,12,28H2,(H,29,33)(H,34,35)	KRZJZRLBSHPMQU-UHFFFAOYSA-N	300349	US9593110, 16-25::BDBM300350	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300349	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300349&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252366	475741916							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574806	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C21H19ClFN3O5/c22-13-5-6-16(23)15(8-13)12-3-1-11(2-4-12)7-14(9-17(24)21(29)30)25-20(28)18-10-19(27)26-31-18/h1-6,8,10,14,17H,7,9,24H2,(H,25,28)(H,26,27)(H,29,30)	QCZMQFCOMDWYEP-UHFFFAOYSA-N	300351	US9593110, 16-27::BDBM300352	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300351	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300351&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252337	475744384							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574807	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(O)no1)C(O)=O	InChI=1S/C21H19ClFN3O5/c22-13-5-6-16(23)15(8-13)12-3-1-11(2-4-12)7-14(9-17(24)21(29)30)25-20(28)18-10-19(27)26-31-18/h1-6,8,10,14,17H,7,9,24H2,(H,25,28)(H,26,27)(H,29,30)	QCZMQFCOMDWYEP-UHFFFAOYSA-N	300351	US9593110, 16-27::BDBM300352	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300351	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300351&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252337	475744384							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574808	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1ncccn1)C(O)=O	InChI=1S/C22H20ClFN4O3/c23-15-6-7-18(24)17(11-15)14-4-2-13(3-5-14)10-16(12-19(25)22(30)31)28-21(29)20-26-8-1-9-27-20/h1-9,11,16,19H,10,12,25H2,(H,28,29)(H,30,31)	JEDXLJDLMAMYIV-UHFFFAOYSA-N	300353	US9593110, 16-29	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300353	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300353&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252423	475744746							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574809	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1coc(=O)[nH]1)C(O)=O	InChI=1S/C21H19ClFN3O5/c22-13-5-6-16(23)15(8-13)12-3-1-11(2-4-12)7-14(9-17(24)20(28)29)25-19(27)18-10-31-21(30)26-18/h1-6,8,10,14,17H,7,9,24H2,(H,25,27)(H,26,30)(H,28,29)	FJWSTJQIRZEXKR-UHFFFAOYSA-N	300354	US9593110, 16-31	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300354	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300354&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			118252479	475745278							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574810	Cc3cc(C(=O)N[C@H](Cc2ccc(c1cc(Cl)ccc1F)cc2)C[C@H](CC#N)C(=O)O)sn3	InChI=1S/C24H21ClFN3O3S/c1-14-10-22(33-29-14)23(30)28-19(12-17(8-9-27)24(31)32)11-15-2-4-16(5-3-15)20-13-18(25)6-7-21(20)26/h2-7,10,13,17,19H,8,11-12H2,1H3,(H,28,30)(H,31,32)	ZWZGVLPNUIMUHJ-UHFFFAOYSA-N	300355	BDBM300356::US9593110, Example 52-1	Neprilysin	Homo sapiens	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300355&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			178255211	475743464							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574811	Cc1cc(sn1)C(=O)N[C@@H](C[C@@H](CC#N)C(O)=O)Cc1ccc(cc1)-c1cc(Cl)ccc1F	InChI=1S/C24H21ClFN3O3S/c1-14-10-22(33-29-14)23(30)28-19(12-17(8-9-27)24(31)32)11-15-2-4-16(5-3-15)20-13-18(25)6-7-21(20)26/h2-7,10,13,17,19H,8,11-12H2,1H3,(H,28,30)(H,31,32)	ZWZGVLPNUIMUHJ-UHFFFAOYSA-N	300355	BDBM300356::US9593110, 52-1	Neprilysin	Human	 6.60								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300355	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300355&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			166596287	475743464							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574812	N[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cc(n[nH]1)-c1cnccn1)C(O)=O	InChI=1S/C25H22ClFN6O3/c26-16-5-6-19(27)18(10-16)15-3-1-14(2-4-15)9-17(11-20(28)25(35)36)31-24(34)22-12-21(32-33-22)23-13-29-7-8-30-23/h1-8,10,12-13,17,20H,9,11,28H2,(H,31,34)(H,32,33)(H,35,36)	LQLZLUYOKNTKJU-UHFFFAOYSA-N	300357	US9593110, 16-33	Neprilysin	Human	<1.00								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300357	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300357&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			166596360	475743977							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
574813	OC(=O)[C@H](CC#N)C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnsc1	InChI=1S/C23H19ClFN3O3S/c24-18-5-6-21(25)20(11-18)15-3-1-14(2-4-15)9-19(10-16(7-8-26)23(30)31)28-22(29)17-12-27-32-13-17/h1-6,11-13,16,19H,7,9-10H2,(H,28,29)(H,30,31)	FORWOHZNUCVCTC-UHFFFAOYSA-N	300358	US9593110, 52-3	Neprilysin	Human	 2.20								US Patent		10.7270/Q2MC9224		aid1796033	US9593110	Fleury, M; Beausoliel, A; Hughes, AD; Long, DD; Wilton, DA	3/14/2017	3/14/2019	Theravence Biopharma R&D Ip	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=300358	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6595&target=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=300358&enzyme=Neprilysin&column=ki&startPg=0&Increment=50&submit=Search			126654100	475741958							1	MGKSESQMDITDINTPKPKKKQRWTPLEISLSVLVLLLTIIAVTMIALYATYDDGICKSSDCIKSAARLIQNMDATTEPCTDFFKYACGGWLKRNVIPETSSRYGNFDILRDELEVVLKDVLQEPKTEDIVAVQKAKALYRSCINESAIDSRGGEPLLKLLPDIYGWPVATENWEQKYGASWTAEKAIAQLNSKYGKKVLINLFVGTDDKNSVNHVIHIDQPRLGLPSRDYYECTGIYKEACTAYVDFMISVARLIRQEERLPIDENQLALEMNKVMELEKEIANATAKPEDRNDPMLLYNKMTLAQIQNNFSLEINGKPFSWLNFTNEIMSTVNISITNEEDVVVYAPEYLTKLKPILTKYSARDLQNLMSWRFIMDLVSSLSRTYKESRNAFRKALYGTTSETATWRRCANYVNGNMENAVGRLYVEAAFAGESKHVVEDLIAQIREVFIQTLDDLTWMDAETKKRAEEKALAIKERIGYPDDIVSNDNKLNNEYLELNYKEDEYFENIIQNLKFSQSKQLKKLREKVDKDEWISGAAVVNAFYSSGRNQIVFPAGILQPPFFSAQQSNSLNYGGIGMVIGHEITHGFDDNGRNFNKDGDLVDWWTQQSASNFKEQSQCMVYQYGNFSWDLAGGQHLNGINTLGENIADNGGLGQAYRAYQNYIKKNGEEKLLPGLDLNHKQLFFLNFAQVWCGTYRPEYAVNSIKTDVHSPGNFRIIGTLQNSAEFSEAFHCRKNSYMNPEKKCRVW	6XVP,6SVY,6SUK,5JMY,6THP,6GID,2YB9,2QPJ,1Y8J,1R1J,1R1I,1R1H,1DMT	Neprilysin	NEP_HUMAN	P08473	A8K6U6 D3DNJ9 Q3MIX4